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ABSTRACT
Traumatic brain injury (TBI) is a major source of disability in modern
societies. However, there are no good pharmacological strategies for treating
long-term TBI complications because we do not fully understand the injury
processes that occur afterward. Moreover, a significant percent of patients
entering the emergency room with TBI have a blood alcohol level above the legal
limit. Alcohol use and intoxication is a widespread issue in our society. Binge
drinking is the most common way in which alcohol is consumed, and alarmingly,
Americans of all age groups binge drink on a frequent basis. Despite the
prevalence of alcohol intoxication seen together with TBI, how it affects the brain
injury and recovery process is not well understood. Our laboratory has previously
found that a repeated dose of binge alcohol prior to TBI impairs functional
sensorimotor recovery. One means by which the brain responds to injury is the
mobilization of neural precursor cells produced by neurogenesis. However, the
effect of pre-injury binge alcohol exposure on the reactive neurogenesis that
occurs after TBI is not known. Adult neurogenesis is an alternative form of
plasticity, which involves the production of new neurons and may contribute to
functional recovery after TBI. The subventricular zone (SVZ) is one of the brain’s
main neurogenic niches. The experiments in this dissertation therefore sought to
xiii

determine the short and long term effects of pre-TBI binge alcohol on the neural
stem cell responses in the SVZ following brain injury. We assessed the SVZ neural
stem cell response after binge alcohol and TBI by utilizing the proliferation marker
5-bromo-2’-deoxyuridine (BrdU) along with other markers for neurogenesis such
as Doublecortin. We found that binge alcohol did not affect short and long term
lesion size (as measured at 24 hours, 7 days and 6 weeks post TBI). As expected,
TBI alone significantly increased SVZ proliferation bilaterally 24 hours post injury.
Surprisingly, binge alcohol alone also significantly increased proliferation
bilaterally in the SVZ at the 24 hour time point. A combined binge alcohol and TBI
regimen resulted in decreased SVZ proliferation bilaterally at 24 hours and 7 days
post-TBI. Furthermore, when assessed at 6 weeks after TBI, binge alcohol
significantly decreased SVZ neuronal differentiation. While we observed that TBI
alone increased migration toward the rostral migratory stream (RMS), binge
alcohol did not affect either RMS or perilesional migration post-TBI. Taken
together, the results from this dissertation suggest that pre-TBI binge alcohol
negatively impacts functional recovery by decreasing short-term neural stem cell
proliferative responses as well as long-term neuronal differentiation of these
proliferative cells in the SVZ.
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CHAPTER ONE
OVERVIEW AND HYPOTHESIS
The prevalence of traumatic brain injury (TBI) in our society is striking with
1.7 million occurrences annually (CDC 2010). Many survivors are faced with
debilitating outcomes such as deficits in sensory or motor function and increased
risk for mood and dementia disorders (Langlois et al 2006). Yet, no
pharmacological treatments have been found to be effective at treating long-term
TBI effects. Important to this study, up to 43% of TBI patients entering the
emergency department have blood alcohol levels above the legal limit of 0.08%
(Talving et al 2010). Clinical studies indicate that being intoxicated at the time of
head injury leads to delayed recovery (Schutte & Hanks 2010). Binge drinking has
become one of the most common ways in which alcohol is abused according to a
2012 CDC report. A recent finding from our group has shown that using a rat
model of TBI and binge alcohol, the recovery in skilled sensorimotor task
performance is slower in alcohol-exposed animals (Vaagenes et al 2015). The
cellular and molecular underpinnings of the impact of this binge pattern of
alcohol consumption on TBI recovery has yet to be elucidated, and we believe
that a more fundamental understanding of TBI and binge alcohol will help in
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designing better therapeutic interventions for patients. One way in which the
brain compensates after an injury such as TBI is to increase neurogenesis in
various regions such as the subventricular zone (SVZ). Neurogenesis is thought to
improve functional recovery by incorporation of new neurons that take on the
previous functions of the damaged neurons. The goal of this dissertation was to
determine how TBI affects neurogenesis in the SVZ and if alcohol binge prior to
TBI leads to a reduction in neurogenesis. The results from this dissertation will
show directly how TBI affects the three most important parameters of
neurogenesis: proliferation, differentiation and migration.
We therefore hypothesize that: A binge pattern of alcohol consumption prior to
traumatic brain injury results in a decrease in the neural stem cell (NSC)
response from the SVZ.
This hypothesis will be tested by the following specific aims:
Aim 1: Determine the effect of binge alcohol and TBI on SVZ proliferation:
Proliferation will be measured by BrdU staining using unbiased stereology at
early time points of 24 hours and 7 days after TBI.
There will be 4 experimental groups: one group will receive binge alcohol
(3g/kg/day, 3 days, by oral gavage) and TBI (controlled cortical impact to
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sensorimotor cortex); the next group will receive vehicle gavage (isovolumic
water) and TBI; another group will receive binge alcohol and sham TBI
(craniotomy without cortical damage) and the final group will receive vehicle
gavage and sham TBI. Immediately after surgery, all rats will receive
bromodeoxyuridine (BrdU) (100mg/kg/day ip for up to 7 days) and survive for 1
day after TBI or 7 days after TBI. At 1 day or 7 days after TBI, rats will be
euthanized and transcardially perfused. Brains will be cryosectioned and
immunostained for BrdU and visualized by Diaminobenzidene (DAB) labeling. We
will be using stereology to assess the number of BrdU positive cells, which is a
measure for cellular proliferation.
Aim2: At 6 weeks after TBI, determine the effect of binge alcohol and TBI on
neuronal differentiation in the SVZ and the migration of new neurons to the
perilesion area and olfactory bulb. Differentiation will be determined by
measuring BrdU and Doublecortin (DCX) staining. Migration will be measured by
examining BrdU and DCX staining at target migrating sites (perilesional area and
rostral migratory stream).
Animals will undergo the same basic experimental conditions as outlined in
aim 1. They will receive BrdU (100mg/kg/day, ip) for 7 days following TBI to label
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all proliferation and will survive for 6 weeks. At 6 weeks after TBI, rats will be
euthanized and brain tissues processed. We will use stereology to assess the
number of NSC with a combination of markers including BrdU for proliferation
and DCX for differentiation and migration.

CHAPTER TWO
REVIEW OF RELATED LITERATURE
Traumatic Brain Injury
Traumatic Brain Injury (TBI) is one of the major sources of disability in our
modern society (Diaz-Arrastia et al 2014). In the United States, about 1.7 million
people suffer from TBI every year (Coronado et al 2012) About 3% of these people
die due to the severity of the injury or the complication that follows TBI (Corrigan
et al 2010). Of the 97% of the people who survive, many face the difficult
prospect of living with long-term disability. Additionally, the military faces
challenges dealing with TBI, as it had been called the “signature wound of the war
in Iraq and Afghanistan”(Lawhorne 2010).
TBI is divided into two distinct phases, the primary and secondary injury
processes. Primary injury is the immediate, direct biomechanical insult causing
rapid brain tissue deformation and cortical, sub-cortical or axonal tissue damage
and death. The results of primary injury are either focal or diffuse lesions.
Primary injury often involves vasculature damage leading to bleeding; this type of
bleeding can occur anywhere within the head such as epidural, subdural,
intracerebral hematoma, contusion and laceration. Epidural hematoma is when a
5
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blood vessel is torn and blood pools between the skull and the meninges (also
known as extradural hematoma). When the blood pools between the dura and
the arachnoid, it is called subdural hematoma. Subarachnoid hematoma is when
blood collects in the space between the arachnoid membrane and the pial mater
covering the brain (this space is also known as the subarachnoid space). Usually,
subarachnoid hematoma poses poor prognosis for TBI patients especially if cooccurring with loss of consciousness (Servadei et al 2002). Intracerebral
hematoma is when blood bleeds into the brain parenchymal space. Hematoma is
diagnosed by CT and MRI scans and in certain cases, needs to be evacuated.
Clinical presentation in the emergency room is an important first step
toward the treatment of TBI. The presence of symptoms such as loss of or altered
consciousness, headaches, nausea, vomiting or dizziness in trauma patients
warrants that CT scan should be performed immediately. CT is the procedure of
choice to initially assess patients with cranial trauma as it is able to detect skull
fractures and hematomas. Patients who present without obvious signs of external
trauma still need to be closely evaluated especially if they are intoxicated. Alcohol
intoxication can lead to difficulty in diagnosing subdural hemorrhages.

7

Glasgow Coma Scale (GSC)
Eye Opening
Best Motor Response
Best Verbal Response
Spontaneous:E4 Obeys commands:M6
Oriented:V5
To voice:E3
Localizes:M5
Confused conversation:V4
To pain:E2
Withdrawal:M4
Inappropriate words:V3
None:E1
Abnormal flexion:M3
Incomprehensible sounds:V2
Extensor posture:M2
None: V3
None:M1
Score=(E+M+V)=3 to 15
Table 1: The GCS is widely used by clinicians to diagnose the extent of functional
deficits after TBI. Adapted from (Teasdale & Jennett 1976).
Once head injury is ascertained in patients, the extent of injury can be
further categorized into mild, moderate and severe using the Glasgow Coma Scale
(GSC), (see Table 1). The GSC is used by clinicians to communicate the assessment
of trauma patients and the GSC score is an important prognosticator of clinical
outcome. Mild TBI is classified as GCS 14-15, moderate TBI is 9-13 and severe TBI
as 3-8 (Narayan 1997). The GSC relies on the examination of eye, verbal and
motor function to evaluate the patients. For instance, a patient with mild TBI
would be conscious and responsive to verbal communication; however, this
patient might be disoriented and have difficulty sensing painful stimuli. Mild TBI
presents a problem in diagnosis, as the patients might not come into the clinic to
report it. Additionally, patients with mild TBI might not have any indication of
trauma on CT scans and the clinical symptoms might show up over the course of
several weeks (Zollman 2011). In contrast, a moderate TBI patient would be
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conscious but could be much more disoriented and would have impaired ability to
communicate. Finally, severe TBI patients would be unconscious and would not
be able to communicate or open their eyes (Zollman 2011).
Depending on the severity of TBI, hypotension and hypoxia might be an
issue for the patient; therefore endotracheal intubation might need to be
performed. Overall, not much can be done regarding primary TBI injury. Head
injuries are stabilized in the emergency room and the hematomas are removed or
cerebral spinal fluid evacuated in the case of elevated intracranial pressure (ICP).
The secondary TBI injury process is the main target for therapeutic
intervention. Over hours to months and years after the initial primary trauma,
additional complications such as intracranial hemorrhage, brain tissue swelling,
elevated ICP, hypoxic and ischemic conditions can occur (Morales et al 2005).
Various molecular changes occur that characterize the secondary injury process:
elevation of pro-inflammatory cytokines, increase in oxidative stress and
excitotoxicity. All of these process might culminate in prolonged neuronal
inflammation and degeneration.
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Elevated Intracranial Pressure and Cerebral Perfusion Pressure
In a normal adult, ICP is around 15mmHg. A sustained increase of over
20mmHg is not well tolerated in the case of injury and is associated with
increased mortality (Eisenberg 1988, Narayan 1982). Sustained elevation in ICP
after brain injury can lead to cerebral ischemia or even more severely, brain
herniation. Ventriculostomy is a procedure in which a silicon catheter is used to
measure ICP and to drain the CSF if needed. Additionally, mannitol can be given
intravenously to effectively lower ICP.
Cerebral perfusion pressure (CPP) is a measure of how well blood flows in
the brain after an injury. CPP is defined as CPP=MAP-ICP; where CPP is MAP
(mean arterial pressure) minus ICP (intracranial pressure). CPP below 50mmHg for
an extended amount of time is dangerous for the brain because the perfusion
cannot match the brain metabolic needs and can lead to cerebral ischemia (Katz
et al 2006).
Secondary injury processes start as a consequence of the trauma forces
involved in the primary injury process. Calcium homeostasis is first disrupted
(Bains & Hall 2012). During normal conditions, calcium is tightly regulated such
that its concentration in the cells of the CNS is very low and the extracellular
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concentration is much higher. Primary injury leads to cells unable to maintain this
gradient and more calcium enters the cell cytosol. This leads to depolarization and
release of glutamate which is an excitatory neurotransmitter. An excess of
extracellular glutamate leads to a process called excitotoxicity. Excitotoxicity
happens when excess extracellular glutamate binds to NMDA and AMPA
receptors. These receptors are ligand-gated ion channels which allow even more
extracellular calcium to enter the cell leading to more glutamate release. This
becomes a self-perpetuating mechanism leading to cell death through the
mechanism of apoptosis. The disruption of chemical gradients of different ions in
the brain combined with decreased oxygen due to hemorrhage leads to reduced
ATP production which can lead to issues like disrupted protein synthesis and
disruption of antioxidant systems such as the glutathione peroxidase system.
Collectively, the brain experiences oxidative stress because free radicals such as
superoxide and peroxinitrite are elevated. These free radicals are extremely
harmful to the cell because carbon in lipids, nucleic acids and proteins can react
with these reactive oxygen species (ROS) (Hall et al 2010). Oxidative stress,
besides affecting neurons and glia, can be detrimental to the blood brain barrier
(BBB). The BBB serves as the vascular filtering of the brain; it allows necessary
nutrients to enter the CNS and waste products to exit while blocking undesirable
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compounds access to the brain (Smith et al 1994). The cellular composition of the
BBB is made up of endothelial cells that form tight junctions with each other.
Surrounding these endothelial cells are pericytes, smooth muscle cells and
astrocytes which form a structure called end feet (Chodobski et al 2011).
Following TBI, the BBB breaks down and becomes more leaky. This might be due
to an increase in lipid peroxidation, which is a consequence of elevated ROS.
Blocking lipid peroxidation was showed to reduce BBB permeability after TBI
(Smith et al 1994).
Reduced ATP synthesis after TBI also impairs the active transport of
pyruvate into the mitochondria leading to a decrease in the Krebs cycle. As a
result, cells enter a Pasteur shift, a process in which normal aerobic respiration is
shifted to anaerobic respiration. Glucose is broken down incompletely leading to
excess lactic acid accumulation which results in a condition called lactic acidosis
(Hall 2012).
Brain edema is a characteristic physiological response of the brain to injury
and is thought to have two distinctive components, vasogenic and cytotoxic.
Vasogenic edema is a result of increased blood brain barrier (BBB) leakage after
TBI. Tight junctions that make up the BBB are broken down after brain injury and
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allow extravasations of fluid and proteins into the interstitial space of the brain
parenchyma. Cytotoxic edema, also known as cellular edema, happens at the
individual cell level, which is due to altered cellular ion homeostasis and cell
membrane dysfunction. The time course of vasogenic and cytotoxic edema is
different, with vasogenic edema happening early on right after primary TBI injury
while cytotoxic edema happens in a much more delayed manner. Brain edema
generally is maximal around 24 to 48 hours (Marmarou 1994).
Brain inflammation is an important component of TBI secondary injury and
has both acute and chronic aspects. Inflammation is thought to be both beneficial
and detrimental and is composed of both released factors (IL-1b, eicosanoids) and
cellular factors (neutrophils and macrophages) (Popovich et al 1999, Schoettle
1990, Shapira 1992, Toulmond & Rothwell 1995). IL-1b is an important
inflammatory mediator and is found to be elevated in CSF (Marion et al 1997) and
contused brain tissue of TBI patients (Clark et al 1999). Additionally, other
cytokines have subsequently been found to be playing roles in post-TBI
inflammation including IL-6 (Kossmanna 1996), and IL-8 (Kossmann 1997).
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Different Types of TBI
There are two main types of TBI, closed, and penetrating brain injury. In
closed TBI, the injury can occur due to two primary general means, static and
dynamic loading (Graham 2002). Static loading is when a slow moving force is
applied to the head; an example of this would be the head being crushed by a
heavy object such as a car. In dynamic loading causing TBI, which occurs more
frequently, the head is subjected to sudden acceleration and deceleration forces
(Stålhammar 1986). Dynamic loading can further be divided into two types,
impulsive or impact loading. In the impulsive dynamic loading scenario, the head
is set into motion suddenly or brought to a stop suddenly. This is most commonly
seen in whiplash type of injury. An example of an impact dynamic loading
situation would be a blunt object such as a baseball bat striking the head. Both
impulsive and impact loading types of TBI produce tissue deformation due to the
mechanical forces involved.
The other major type of TBI is penetrating brain injury. This type of injury is
associated with armed combat, such as gunshot and missile wounds. The severity
of penetrating TBI is determined by the size of the projectile, shape, mass,
velocity and location of impact (Morales et al 2005).
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Blast Injury
TBI resulting from blasts from explosive devices (i.e Improvised explosive
devices or IED’s) is increasingly recognized as being mechanistically and
physiologically distinct compared to traditional penetrating and closed head TBI
(Ling et al 2009). It is thought that up to 60% of deployed military personnel are
potentially exposed to blast TBI. Furthermore, there are some important links
between blast TBI and post traumatic stress disorder (PTSD). Primary blast results
in forces emanating from the explosion in the form of pressure wave transients
causing injuries to the brain much like closed TBI would. Interestingly, common
diagnoses among blast TBI patients are diffuse brain edema, hyperemia, and
vasospasm.
Concussive Sport Head Injury
It had been recognized that repetitive exposure to mild TBI that is
experienced by certain athletes such as boxers and football players could result in
a condition called chronic traumatic encephalopathy (CTE). Signs and symptoms
of this condition are somewhat similar to Parkinson’s disease in which the
patients have gait disorder, slurred speech, neuropsychiatric and behavioral
symptoms (Gardner et al 2013).
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Animal TBI Models
Modeling of human TBI in laboratory animals requires that the clinical
symptoms seen in human patients be replicated in the model. For instance,
primary injury to the cortex must be the same as seen in humans and secondary
injury processes should closely mimic that of the human condition. Additionally, a
good model needs to have parameters of the injury adjusted so that it can
produce graded severity of TBI injury (mild, moderate and severe). Furthermore, a
good model needs to be reproducible between different laboratories. To this
end, models that had been shown to produce focal brain injury are midline fluid
percussion (MFP), controlled cortical impact (CCI) and weight drop (Figure 1).
However, in addition to the focal nature of the injuries that these models
produce, there is an additional axonal injury when the injury severity reaches a
threshold.
The weight drop model relies on gravitational force of a free falling object
to produce a focal TBI (Feeney et al 1981). In this model, rat or mice are
anesthetized and restrained to stabilize the head during impact as to ensure
reproducibility (Figure 1A). The skull of the animal is exposed and craniotomy to
expose the brain can be performed; however, another variation on this model is
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without craniotomy. The severity of TBI can be adjusted by changing the mass of
the weight or its height in which it is dropped from. A strong advantage of the
weight drop model is its convenience; it is very easy and quick to set up for the
investigator. The weight drop model is able to reproduce clinical symptoms of
concussive TBI such as cortical cell loss, axonal injury and in more severe TBI
parameters, contusions and hemorrhages. Additionally, behavioral dysfunctions
are reproduced in animals with the weight drop models such as impairments in
motor function as well as cognitive deficits and these behavioral deficits do
correlate to injury severity (Chen et al 1996, Tang et al 1997). However, there are
also some strong drawbacks of the weight drop model: the lesion produced can
be inaccurate (especially when no craniotomy is performed) and there are
chances the animals might get a secondary “rebound” injury. Furthermore, this
model had not been evaluated in rodents for long-term effects or recovery
making it less applicable to human TBI.
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Three Widely Used Animal Models of TBI

A

B

C

Figure 1: Three well characterized models of TBI. A. The weight drop model;
adapted from (Michael 2016). B. The controlled cortical impact model; adapted
from (Michael 2016). C. The lateral fluid percussion model; adapted from (Kabadi
et al 2010).
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The midline fluid percussion (MFP) TBI model was first demonstrated in cat
and rabbit (Härtl et al 1997, Hayes et al 1987); however, it was later adapted for
use in rat (Dixon et al 1987, McIntosh et al 1987). In the MFP model, the skull is
exposed and a craniotomy performed (at the midline) to expose the brain. A
pendulum is the source of kinetic energy that causes a fluid bolus to strike the
dural surface of the brain (Figure 1C). The fluid force extends into the epidural
space causing diffuse loading of the brain (Sullivan et al 1976). The severity of
MFP TBI can be varied by the height at which the pendulum is released. The MFP
model leads to focal injury in the gray matter of areas directly in and around the
site of contact and can lead to intraparenchymal and subarachnoid hemorrhage
(Graham et al 2000). Additionally, depressed cerebral blood flow is observed for
around 24 hours post TBI (Ozawa et al 1991). Animal models of MFP TBI have
deficits in cognition and motor functions (Dixon et al 1987). A major disadvantage
of MFP is the high mortality rate because the percussive force acting on the brain
often leads to herniation and brainstem damage.
The controlled cortical impact (CCI) TBI model relies on a rigid impactor that
is either pneumatic or electromagnetically powered (Figure 1B). The CCI was first
demonstrated in ferret (Lighthall 1988) and subsequently adapted for use in rat
(Dixon et al 1991) and mouse (Smith et al 1995). The cortical locations of the CCI
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model can be varied; for instance, midline CCI has been performed (Lighthall
1988) and lateral cortices (Chen et al 2003). Importantly, CCI TBI produces less
mortality due to minimal brain stem damage. The severity of TBI can be greatly
varied by changing the parameter of the impactor such as time, velocity and
depth. There is also no chance of secondary damage due to “rebound” injury. The
CCI TBI model can recreate a variety of clinical signs observed in human TBI
patients such as contusion, intraparenchymal, epidural and subdural hematomas
(Dixon et al 1991, Lighthall 1988), gray and white matter damage, ventricular
enlargement (Dixon et al 1999), and hippocampal and thalamic degeneration (Hall
et al 2005). These widespread effects due to CCI TBI correlate to behavioral
deficits, as impairments in sensorimotor (Fox et al 1998) and cognitive functions
(Scheff et al 1997) are observed for extended periods of time after TBI for up to
one year. An additional and important benefit of the CCI TBI model is its
reproducibility among different laboratories. Due to these reasons, the CCI model
was used in the experiments in this dissertation.
More recently, the military conflicts in the Middle East have demonstrated
the need for developing an animal model for blast injury to study the effect
produced by improvised explosive devices (IED). The injury characteristic of blasts
is rapid pressure waves moving through the brain tissue (Risling & Davidsson
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2012). This could also be accompanied by further non-blast injuries from blunt
trauma either from shrapnel or environmental objects (Sundaramurthy et al
2012). Rodents have been used to model this blast injury, which utilize a unique
shock wave generator. In this model, anesthetized mice are placed in a metallic
tube and subjected to pressure waves, which closely resemble the force produced
by an IED. Diffuse cortical damage, edema and intracranial hematoma are
commonly seen in this model (Svetlov et al 2010).
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Current and Potential Treatments for TBI
The Neurotrauma Pharmacology Workgroup in 2012 (Diaz-Arrastia et al
2014), reviewed the current possible treatments for TBI to identify strengths and
limitations in these drugs. Their findings are summarized below:
Acetylcholinesterase inhibitors (AchEI) increase the concentration of
acetylcholine at the synapse by inhibiting its breakdown. Studies using various
AchEI such as physostigmine (Cardenas et al 1994, McLean et al 1987), donepezil
(Ballesteros et al 2008), and rivastigmine (Blount et al 2002), have shown some
potential benefits for chronic TBI patients with cognitive deficits. Additionally,
pre-clinical trials have shown beneficial effects of AchEI including decreased
neuronal cell death, decreasing hippocampal neural degeneration, reduced BBB
breakdown, decreased vasogenic brain edema and preservation of neurological
functions (Ballesteros et al 2008, Chen et al 1998). However, the majority of
clinical studies on the efficacy of AchEI for TBI were not randomized controlled
trials, and has issues with methodology and small sample sizes; these important
limitations prevented a good assessment of these AchEI drugs. Additionally, there
is no evidence in pre-clinical studies in animals showing the efficacy of AchEIs
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given after an extended period of time after TBI (i.e. delayed administration
paradigm).
Amantadine is a FDA approved antiviral used for the treatment of influenza
A. Additionally, it had some efficacy in the treatment of Parkinson’s disease but
the exact mechanism is not fully elucidated. Studies have suggested that
amantadine increases dopamine (DA) concentration either by decreasing DA
reuptake or increasing DA synthesis (Bales et al 2009). Additionally, there is some
evidence suggesting amantadine increases post-synaptic DA receptor expression
(Gianutsos et al 1985). An interesting piece of evidence that might explain
amantadine’s beneficial effect for TBI patients is its role as a noncompetitive
antagonist of NMDA receptors (Stoof et al 1992), which is the main mediator of
excitotoxicity. One study using CCI as a TBI model and amantadine treatment
commenced one day after TBI showed a modest beneficial effect in the Morris
water maze (MWM) (Dixon et al 1999). However, the pre-clinical animal studies
for amantadine as a treatment for TBI is still lacking; more research needs to be
done on the time-course and duration of amantadine treatment. In addition, the
different types and severity of TBI paradigms need to be tested in amantadine
research.
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Cyclosporine A (CsA) maintains mitochondrial membrane potential and
prevents mitochondrial induced damage after TBI. In various animal models of
TBI, cyclosporine had shown positive effects in axonal injury and learning and
memory (Alessandri et al 2002, Heuvel et al 2004). CsA also has immunomodulating effects, which is another aspect in which it could be potentially
beneficial for TBI patients. There are several clinical studies that showed CsA
improves histological outcomes such as decreased axonal damage and decreased
contusion size. However, there are fewer studies that showed improved
functional outcomes. One study using CCI as a TBI model did not show CsA
significantly improved cognitive outcome in rat (Baki et al 2010). However, more
research is needed in regard to the CsA administration route because CsA is
thought to have poor BBB permeability. Additionally, more information about the
ideal time-course of CsA treatment, and different outcome measures are needed
to completely evaluate CsA efficacy as a treatment for TBI.
Erythropoietin (EPO) is a cytokine that plays an important role in
erythropoiesis and has been found to have positive effects after TBI such as
decreasing excitotoxicity and nitric oxide toxicity, decreasing cell death, increasing
neurogenesis and angiogenesis (Ozisik et al 2007, Xiong et al 2011, Zhang et al
2010). Additionally, EPO has antioxidant and anti-inflammatory effects (Ozisik et
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al 2007). Erythropoietin acts through the EPO receptors, which are present in
many cell type of the CNS. However, EPO might act through other mechanisms as
EPO receptors are not needed to mediate some of the effects of erythropoietin.
EPO has been extensively studied in the rodent system and using different models
of TBI, and its dosing and route of administration have been well characterized.
There are different on-going clinical trials using EPO as treatment for severe TBI.
One study recruiting patients with subarachnoid hemorrhage showed significant
positive effects with regards to vasospasm, ischemic deficit and improved
discharge outcome when EPO was administered acutely (Tseng et al 2009).
Another non-randomized retrospective study again with severe TBI patients
showed that EPO administered sub-acutely (within 14 days of TBI) resulted in
lower hospital mortality (Heeschen et al 2003). However, more pre-clinical studies
are needed to explore EPO administration for moderate or mild cases of TBI or
more delayed administration.
Glyburide is a sulfonylurea that binds to Sur1 and thus blocks the KATP
channels. It is approved for use as an insulin secretagogue and is used to treat
patients with adult onset diabetes. Sur1 is an adenosine triphosphate binding
cassette transporter; Sur1 associates with other pore forming subunits to form
ion channels (Diaz-Arrastia et al 2014). After TBI, non-selective cation channels
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(NCCa-ATP) in which Sur1 is a component of, are increased in expression levels in
neurons and endothelial cells of the CNS. Pre-clinical studies have found
beneficial effects of glyburide in animal TBI models, including reduced
inflammation, hemorrhage and vasogenic edema. One study showed glyburide
treatment led to reduction in secondary hemorrhage (Simard et al 2009); and
another study showed improved performance in the Morris water maze (Patel et
al 2010). These studies administered glyburide shortly after TBI (within 10 hours)
so more studies that use a delayed treatment paradigm are needed to fully
evaluate glyburide. Additionally, glyburide has been used in several retrospective
clinical studies for the treatment of ischemic stroke, where glyburide treated
patients suffered less hospital mortality and decreased edema. A phase II trial of
glyburide for moderate to severe TBI has started. In this study, glyburide
treatment commences at 8 hours after TBI and continues for 72 hours.
Growth hormone (GH) is secreted by the anterior pituitary gland and has
important anabolic effects by acting through the GH receptors. About 20% of TBI
patients have GH deficiencies, which might be due to direct or indirect injury to
the pituitary or hypothalamus (Benvenga et al 2000, Wilkinson et al 2012). Using a
rat model of TBI, one study showed that increasing GH leads to increased motor
and cognitive recovery (Saatman et al 1997). Clinical studies looking at TBI
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patients with GH insufficiency/deficiency have found that administration of
recombinant human GH at the chronic stage by daily subcutaneous injections for
up to 12 months showed improved cognitive outcomes (Devesa et al 2013,
Reimunde et al 2011). However, other clinical studies suggest that GH given in the
acute stage is detrimental (Demling 1999, Takala et al 1999). Overall, GH
administration still holds strong promise as an effective chronic TBI treatment.
However, more preclinical studies are needed to study the exact molecular
mechanism in which GH acts.
Lithium is an effective pharmacological treatment for bipolar disorder. It
had been found to be neuro-protective by reducing excitotoxicity, decreasing
ischemia related injury and decreasing cell death by apoptosis, attenuates proinflammatory cascades and preserves the function of the BBB (Dash et al 2011,
Shapira et al 2007, Yu et al 2012a). For instance, in an animal model of TBI, lithium
was given shortly after injury and continued for 3 weeks showed reduced TBI
lesion size and improved behavioral recovery (Yu et al 2012b). Despite favorable
preclinical studies, no well-controlled clinical trials have test lithium for the
treatment of TBI. There are some small case studies in which lithium was given to
bipolar patients after TBI of varying severity; however, the primary outcome
measurements were aggression and agitation. Overall, lithium is a well-tolerated
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drug that needs further clinical testing as a treatment for TBI. Therapeutic
windows and effective outcome measurements need to be used to effectively
evaluate the usefulness of lithium.
Methylphenidate is used to effectively increase synaptic concentration of
DA and norepinephrine; it block DA transporters and inhibits DA and
norepinephrine reuptake (Moeller et al 2012). Atomoxetine also increases
synaptic concentration of DA and norepinephrine through similar mechanisms as
methylphenidate (Swanson et al 2006). Both of these drugs are FDA approved for
the treatment of attention deficit hyperactivity disorder. In animal TBI models,
methylphenidate treatment leads to increased striatal dopaminergic
neurotransmission and subsequently increased spatial learning and motor
recovery (Wagner et al 2009). Similarly, atomoxetine leads to better Morris water
maze performance after TBI (Reid & Hamm 2008). In the clinic, methylphenidate
is well tolerated in patients with TBI (Alban et al 2004). The treatment windows
for several studies started at several weeks to years after injury (sub-acute to
chronic phase of TBI), and the doses ranged from a single one-time dose to up to
30 days. Overall, these studies were not conclusive about the effects of
methyphenidate due to small sample size, limited outcome measures and not
well-controlled injury and administration parameters. Furthermore, there is
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currently no completed clinical study looking at the effect of atomoxetine on post
TBI recovery. Overall, methylphenidate and atomoxetine have promising effects
on TBI recovery in experimental animal TBI models, yet further clinical work that
utilizes large sample sizes are needed to evaluate its true therapeutic potential in
human TBI patients.
Minocycline is a member of the tetracycline family of drugs. Minocycline
exhibits antimicrobial properties and due to its lipophilic property, it readily
crosses the BBB (Kim & Suh 2009). Minocycline also has anti-inflammatory, antiapoptotic and antioxidant activity at larger doses (at six time the normal dose
used to elicit antimicrobial action) making it an attractive candidate for use in TBI
patients who experience polytrauma. Minocycline was used in several animal
models of TBI, stroke and different neurodegenerative diseases with beneficial
effects shown. It is thought that minocycline’s positive effects after TBI are due to
its ability to block caspase dependent and independent apoptosis events,
inhibition of microglia activation and direct action as an antioxidant by scavenging
reactive oxygen species and decreasing the activity of metalloproteinases (Kim &
Suh 2009). In several animal TBI models of CCI and weight drop, minocycline was
given acutely at 45 minutes and up to 4 hours post injury. Lesion volume was
smaller in minocycline treated animals (Bye et al 2007). In the clinics, high dose
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minocycline is well tolerated in patients with spinal cord injuries, and markers for
inflammation were decreased in these patients. However, no completed clinical
studies have looked at Minocycline as a treatment for acute or chronic TBI.
NAC (N-acetyl cysteine) is a potent antioxidant that had been approved for
the treatment of acetaminophen overdose. NAC is processed in the liver to
become cysteine, which readily crosses the blood brain barrier. In the CNS,
cysteine increases the level of glutathione, which is a potent endogenous
antioxidant. Cysteine can also increase the concentration of extracellular
glutamate (Olive et al 2012). In pre-clinical animal TBI studies, NAC was shown to
decrease markers of oxidative damages (Hicdonmez et al 2006), and decrease
inflammatory mediators IL-1b and TNF-a via an NF-kB dependent mechanism
(Chen et al 2008a). Functionally, NAC was shown to decrease TBI lesion volume (Yi
& Hazell 2005) but other measures of functional recovery were less conclusive
(Thomale et al 2006). Interestingly, NAC appears to have synergistic effects when
combined with minocycline treatment when used in experimental TBI (Baki et al
2010). A recent randomized clinical trial using NAC (dosed for 7 days) to treat
soldiers exposed to blast TBI injury showed significant improvement in recovery.
Therefore, NAC should be further explored in more clinical studies as treatment
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for other types of TBI and in a wider population. Additionally, detailed therapeutic
windows of NAC need to be established.
Progesterone is an endogenous steroid produced in the CNS, reproductive
organs and the adrenal glands. Furthermore, it is found in high concentration in
the brain of both males and females. Progesterone has several potential
mechanisms in which its effect might be beneficial to TBI patients. It has been
shown to enhance myelination (Koenig et al 1995), increase neurogenesis (Liu et
al 2009) and modulate aquaporin expression, which potentially decreases the
aquaporin induced edema post TBI. Additionally, progesterone serves as a
precursor to other neurosteroids with neuroprotective effects. For instance,
allopregnanolone is elevated after oral progesterone administration, which
exhibits potent neuro-protective effects (Sayeed et al 2006). In animal models of
TBI including CCI, progesterone treatment showed decreased edema(Cutler et al
2007) reduced cell death by apoptosis (Cekic et al 2012) and attenuation of proinflammatory mediators such as IL-6, IL-1b, and TNFa (Pan et al 2007). It also was
shown to exhibit antioxidant properties with progesterone treatment decreasing
lipid peroxidation (Roof et al 1997). Interestingly, progesterone affects the Tolllike receptor signaling pathway (Chen et al 2008b), which is the primary
mechanism of alcohol induced CNS inflammation. These animal studies also
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demonstrated enhanced behavioral recovery post TBI as a result of progesterone
treatment (Djebaili et al 2005, Wali et al 2011). In clinical studies using
progesterone or its allopregnanolone metabolite, it is very well tolerated and
significantly reduced mortality when it was given in the acute phase of TBI
(Wright et al 2007). Overall, progesterone holds exciting potential as one of the
most effective treatment for TBI. However, more basic research into the
mechanism of its therapeutic effects is needed. Furthermore, additional
therapeutic windows of progesterone should be tested.
Simvastatin is a 3-hydroxy-3-methylglutaryl coenzyme A (HMGA) reductase
inhibitor used widely for the reduction of serum cholesterol. However, there is
experimental evidence for simvastatin and other statins being beneficial to treat
both acute and chronic TBI. Beneficial effects include reduced brain edema,
improved BBB function, increased cerebral blood flow, attenuated CNS
inflammation, axonal injury and cell death (Diaz-Arrastia et al 2014). Simvastatin
and other statins have been extensively investigated in pre-clinical animal models
of TBI primarily using CCI. Most studies have used oral as the method of
administration and treatment started as late as 24 hours post injury and for 7 to
14 days (Abrahamson et al 2009, Li et al 2009). There is currently an on-going
clinical phase II study using atorvastatin to treat adults with mild TBI
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(NCT01013870). Given the large body of evidence for the beneficial effect of
statins in animal studies, more clinical studies are needed to address other
aspects of statins in TBI treatment such as using more delayed administration and
treating different severity of TBI.
Rehabilitation
Given the limitation in current pharmacological approaches to the
treatment of TBI, especially chronic TBI dysfunction such as sensorimotor deficits,
cognitive and behavioral impairments, rehabilitation remains the most effective
method to treat chronic TBI. Rehabilitation is a holistic approach that involves the
patients, their family and the health care team. According to (Barnes 1999),
rehabilitation consists of three approaches: to reduce disability, acquire new skills
and strategies to reduce the impact of disability, and to alter the environment as
to reduce the impact of the disability as much as possible. For instance, the
approach to reduce disability after TBI could be medications to control spasticity
or bladder control problems. An example of acquiring new skills to cope with the
TBI-acquired disability could be physical therapies designed to improve gait or to
increase stamina so the patient could use the wheelchair for an extended period
of time. The last approach, to modify the environment to reduce the impact of a
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patient’s disability could be modification to the patient home to include a
powered lift or grab rails in the toilet. Goal setting is an important part of
rehabilitation. For instance, setting goals that are realistic and can be broken
down into smaller component goals that can be measured. Valid and reliable
outcome measures also need to be used in evaluating the progress of the
rehabilitation process.
Alcohol and The Brain
Alcohol Use Disorder (AUD) is a major problem in our society with about
7.2% of adults in the United States diagnosed with this disorder. This population is
approximately 17 million people. AUD is twice as prevalent in men as compared
to women (NIAAA 2012). Additionally, approximately 855,000 adolescents from
12-17 years of age are also diagnosed with AUD. The Diagnostic and Statistical
Manual of Mental Disorders (DSM) guide recently released a new classification for
AUD in the new DSM-5. AUD is categorized by DSM-5 based on the symptoms
reported by the patients. Out of the 11 possible symptoms, AUD is defined based
on severity. Mild is having a combination of 2 to 3 symptoms, moderate as having
the presence of 4 to 5 symptoms and severe as having 6 or more symptoms
(Table 2).
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2
3
4
5

6
7
8

9

10

11

Had times when you ended up drinking more, or longer, than you
intended?
More than once wanted to cut down or stop drinking, or tried to, but
couldn’t?
Spend a lot of time drinking? Or being sick or getting over other
aftereffects?
Wanted a drink so badly you couldn’t think of anything else?
**This is new to DSM-5**
Found that drinking-or being sick from drinking-often interfered with
taking care of your home or family? Or caused job troubles? Or school
problems?
Continued to drink even though it was causing trouble with your
family or friends?
Given up or cut back on activities that were important or interesting
to you, or gave you pleasure, in order to drink?
More than once gotten into situations while or after drinking that
increased your chances of getting hurt (such as driving, swimming,
using machinery, walking in a dangerous area, or having unsafe sex)?
Continued to drink even though it was making you feel depressed or
anxious or adding to another health problem? Or after having had a
memory blackout?
Had to drink much more than you once did to get the effect you
want? Or found that your usual number of drinks had much less
effect than before?
Found that when the effects of alcohol were wearing off, you had
withdrawal symptoms, such as trouble sleeping, shakiness,
restlessness, nausea, sweating, a racing heart, or a seizure? Or sensed
things that were not there?

The presence of
at least 2 of
these symptoms
indicates an
Alcohol Use
Disorder (AUD).
The severity of
the AUD is
defined as:
Mild:
The presence of
2 to 3 symptoms
Moderate:
The presence of
4 to 5 symptoms
Severe:
The presence of
6 or more
symptoms

Table 2: Guideline for the diagnosis of Alcohol Use Disorder (AUD). Adapted from
NIH Publication No.13-7999.
The effects of alcohol are dependent on the amount that is ingested, its
absorption, metabolism and its level in different organs. Alcohol’s main site of
metabolism is in the liver where two different enzymes are mainly responsible for
its breakdown. First, alcohol is oxidized into acetylaldehyde by the enzyme
alcohol dehydrogense (ADH); acetyladehyde is further oxidized into acetate by
the enzyme aldehyde dehydrogenase (ALDH) (Edenberg 2007).
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There are multiple variations of both enzymes ADH and ALDH; these
different variations of enzymes have different efficiency for converting alcohol
into its by-products. Because of this, a person is more or less at risk of developing
alcoholism and dependence depending on which variants of ADH and ALDH they
express (Hurley 2002). For instance, there are a few factors that determine a
person’s ability to handle alcohol and affect his or her intoxication level and these
include ADH and ALDH alleles, their liver size, and the enzyme expression levels.
All these factors might be one of the reasons why alcohol researchers looking into
its impact on post TBI recovery in patients are so different in their conclusions.
Binge Drinking
One of the most common ways in which alcohol is misused is by binge
drinking. According to the National Institute on Alcohol Abuse and Alcoholism
(NIAAA), binge drinking is defined as having 5 or more drinks for men and 4 or
more drinks for women within a 2 hour time window to reach a blood alcohol
level (BAL) of 0.08-gram percent or more. Binge drinking is very prevalent, as it is
estimated that 1 in 6 adults in the USA binge drink (38 million people) and they do
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so very often (approximately 4 times a month). On average, each person has 8
drinks each time they binge (CDC Vitalsigns, 2012). While most binge drinkers are
not technically categorized in the DSM-5 as having AUD, it is still a major problem
because intoxication due to binge drinking leads to increased chances of health
problems. For instance, one study indicated that alcohol consumption leads to a
greater chance of dying from injuries and sustaining nonfatal injuries (Miller &
Spicer 2012). Furthermore, recent statistics indicated that 88,000 deaths annually
are alcohol related and about 31% of driving deaths are due to alcohol-impaired
driving (NIAAA Alcohol Facts and Statistics 2015).
A high level of alcohol in the human body is very toxic especially to the
liver, which performs most of the alcohol metabolism in the body. According to a
recent report, alcohol is the leading cause of liver cirrhosis (Musso et al 2014).
Alcohol exposure during the developmental stage of human life leads to fetal
alcohol spectrum disorders (FASD) and is estimated to be as prevalent as 20 to 25
cases per 1,000 births (May et al 2009). In terms of the CNS, high levels of alcohol
have been found to have various negative effects. For instance, (Collins et al
1996), found that binge administration paradigm of alcohol 3 times/day
continuous for 4 days which achieved BAL higher than 300mg/dL in rats leads to
neuronal degeneration in several key cerebral and olfactory brain regions.

37

Interestingly, the degeneration in the olfactory region of the brain might explain
why olfactory memory deficits are observed in human alcoholic patients (Shear et
al 1992). Additionally, alcohol has been shown in vitro to increase reactive oxygen
species (ROS) in brain endothelial cell lines, which might indicate that alcohol
decreased BBB functions (Haorah et al 2005). In fact, the metabolism of alcohol
via ADH has been shown to generate free radicals and increase ROS in neuronal
cell lines (Haorah et al 2008) and lead to lipid peroxidation (Altura et al 2002) a
definitive molecular marker for the presence of elevated ROS. High levels of
alcohol administration in rats also lead to neuro-inflammation characterized by
elevated inflammatory mediators such as arachidonic acid and TNFa (Crews et al
2004). However, it is not known whether this neuro-inflammation is a response to
the preceding neuronal degeneration or the cause of the degeneration.
Interestingly, after administration of ethanol into organotypic slice cultures, one
study observed that there were apparent edema effects, which could be blocked
by the diuretic furosemide (Collins et al 1998). Therefore, aquaporin is suspected
to be playing a role in ethanol induced edema in the brain. Alcohol induced
neuro-inflammatory responses such as elevated TNFa and arachidonic acid might
be due to glial TLR-4 activation by alcohol (Alfonso-Loeches et al 2010). The
important process of neurogenesis, in which the brain generates new cells, is also
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potently affected by the presence of alcohol. For Instance, one study found that
using in vitro cultures, ethanol decreased neural stem cell proliferation (Crews et
al 2003). Another study found that in rats, in response to a binge paradigm of
5g/kg alcohol, hippocampal neurogenesis was inhibited (Nixon & Crews 2002).
Alcohol and TBI in The Human Population
Because intoxicated people are more likely to get into dangerous situations
that might result in injuries, it is not surprising that data from trauma centers
indicated that up to 43% of patients entering the emergency department for
severe TBI have blood alcohol levels above 0.08% (Talving et al 2010). Several
researchers studied a group of patients having mild to severe TBI with and
without having been alcohol intoxicated at the time of injury. They used
functional and cognitive outcome measurements that were known to be sensitive
to the effect of TBI. They found that having alcohol intoxication significantly
decreased the Glasgow coma scale score, a functional measure for the severity of
TBI (Schutte & Hanks 2010). Short-term (measured at the time of admission to
inpatient rehabilitation) functional measures showed a significant negative effect
of alcohol intoxication. However, functional and cognitive measures looking at
post rehabilitation or at 1 year post-TBI showed no alcohol effects. One clinical
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study pointed out that alcohol intoxicated patients might preferentially have a
history of other substance abuse, thus the negative functional effects might not
only be due to alcohol intoxication at the time of injury (Corrigan 1995). On the
contrary, some other reports on the effect of alcohol on TBI arrived at different
conclusions. One example is a recent clinical study showing evidence for the
positive impact of BAL at the time of trauma center admission on recovery
(Mohseni 2016). However, there were some important issues with the patient
population included in this study. For instance, the patients with positive BAL
where significantly younger and had less comorbidity.
Animal Models of Alcohol and TBI
Due to the prevalence of alcohol intoxication in TBI patients seen in the
clinics, a number of laboratories had tried to develop a clinically relevant model to
study the biological effect of alcohol on TBI. For instance, one group found some
interesting effects of a chronic alcohol paradigm on recovery after TBI (Zhang et al
1999). Rats were fed with a liquid diet containing ethanol (6.6%). Importantly, at
the time of TBI, the animals had been withdrawn from the alcohol diet for 2 days.
The average daily ethanol consumption was 11.2-13g/kg/day, which was very high
compared to the acute model that our laboratory used (3g/kg/day). Additionally,
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the BAL that was attained at the end of alcohol feeding (6 weeks) was 154mg/dL,
which indicated there was significant tolerance to alcohol in these animals. There
were no significant overall differences in the beam walk scores after TBI between
alcohol/TBI versus vehicle/TBI groups with the exception that on day #2 after
surgery, the vehicle/TBI group did significantly worse. In a spatial learning test,
there was a significant main effect of injury in that TBI lowered the performance
score; however, having alcohol with TBI did not significantly affect performance in
comparison to the control diet.
A different group investigated the effect of longer chronic ethanol
administration (CEAn). They increased the length of time to three months, and in
addition, made the animals intoxicated at the time of injury (Masse et al 2000).
Yet, they observed no significant effect of ethanol on the post-TBI behavioral task
of the Morris water maze (MWM). However, ethanol fed groups appeared to do
better in certain parameters of the MWM. There were no other differences in TBI
parameters such as survival rate or cortical lesion volume. Interestingly, there was
significant BAL tolerance when examining the BAL level at different time points
during the CEAn paradigm.
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Another group investigated the effect of binge ethanol consumption on the
outcome of TBI using the lateral fluid percussion model (LFP) (Prasad et al 2001).
Alcohol was given intragastrically at 3g/kg, Thursday and Friday for four
consecutive weeks follow by moderate injury (animals are intoxicated at time of
injury). Then as before, they used MWM to analyze post injury recovery. There
were no noticeable histological differences between alcohol/TBI and vehicle/TBI
groups. Interestingly, in certain measures of the MWM such as mean search
latency, alcohol TBI group did worse than vehicle TBI. One of the drawbacks of the
studies performed by the Prasad group is the use of the MWM; this behavioral
task is mainly to assess deficits in spatial memory and learning; to detect finer
deficit in motor skills, other test should have been used. What this group had
shown is that acute binge alcohol consumption was more detrimental to post
injury recovery than an “alcoholic”-type of consumption.
Acute single dose alcohol had some interesting effects when given shortly
before a fluid percussion model of TBI (Yamakami et al 1995). In this study, the
dose of alcohol was divided into low (1.5g/kg) and high (3g/kg) and given to rats 2
hours before TBI. For either moderate or high severity TBI, there were 3
conditions, saline, low alcohol and high alcohol. Interestingly, significantly
prolonged hypotension was observed in both alcohol level conditions.
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Neurological motor function was assessed and there was no significant difference
observed between either the alcohol group or vehicle group in moderate TBI.
However, following more severe TBI, the high alcohol level group experienced
higher mortality and worse motor recovery at 24 hours post injury. Furthermore,
post-traumatic cerebral alkalosis was observed in both ethanol treated groups.
Our laboratory used an acute binge alcohol administration paradigm to
investigate its effect on behavioral recovery after TBI (Vaagenes et al 2015).
Alcohol was given at 2g/kg/day (i.p.) for three consecutive days. At the time of TBI
injury, rats were intoxicated and had a blood alcohol level of more than
200mg/dL. Rats were given a TBI in the forelimb area of the sensorimotor cortex
using the CCI model. We used the skilled forelimb reaching task to assess the
recovery of injured rats for up to 7 weeks after TBI and found that the alcohol
administered group had a significantly slower recovery curve with a significantly
lower recovery plateau compared to the vehicle administered group.
There are several mechanisms that could support why alcohol consumption
prior to TBI and intoxication during TBI could result in worse functional outcomes.
For instance, there is evidence that alcohol intoxication could lead to aquaporin
channel dysregulation, which might potentiate edema processes after TBI
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(Sripathirathan et al 2009). Furthermore, alcohol administration can elicit an
inflammatory response, and when combined with TBI, further potentiate that
inflammatory cascade in the secondary injury process (McClain et al 2011).
Another possible mechanism in which alcohol might negatively synergize with TBI
to further worsen TBI outcomes is elevated reactive oxygen species (ROS). Alcohol
metabolism is characterized by the production of ROS. TBI inflammatory cascades
produce elevated ROS, so it is possible that the ROS produced by alcohol
metabolism in combination with the ROS produced by TBI is responsible for the
negative effects of alcohol on post-TBI functional recovery (Le Belle et al 2011).
Another possible CNS pathway which both alcohol intoxication and TBI share is
neurogenesis. High levels of alcohol alone negatively impact neurogenesis
(Hansson et al 2010). We know that after TBI, there is a natural boost in
subventricular and hippocampal-derived neurogenesis and these newly produced
cells might contribute to the recovery process. It is possible that alcohol, by
decreasing neurogenesis, leads to worse or delayed functional recovery as shown
previously in our lab.
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Neurogenesis
For a long time it was thought that we are born with all the neurons that
we would have in our entire lifetime, and this dogma was partly solidified by Cajal
and other neuroscientists of the nineteenth century. However, in 1912, it was
noted by Ezra Allen that there is a zone of proliferation in the area adjacent to the
cerebral lateral ventricle (Allen 1912). However, it was not until the 1960’s when
Altman’s lab released a seminal paper documenting the existence of postnatal
neurogenesis in the mammalian brain using tritiated thymidine autoradiography
(Altman 1962). Since then, many studies have confirmed these two original
observations that there are continual new cells being produced (neurogenesis) in
the adult mammalian brain in mainly two sites, the subventricular zone (SVZ), and
the hippocampal sub-granular zone (SGZ) (Ihrie & Alvarez-Buylla 2011, Spalding et
al 2013).
SVZ Neurogenesis
Particularly important in the context of disease and injuries to the CNS is
that these newborn cells from the SVZ have been detected in the injury sites
(Young et al 2011). The main purpose of SVZ neurogenesis in the rodent brain is
to produce cells to replace those in the olfactory bulb (OB). However, the
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connection between proliferation in the SVZ and the presence of new cells in the
OB was not made until relatively recently (1994) by the laboratory of Arturo
Alvarez-Buylla. Before that, it was believed that the SVZ is a vestigial structure and
new cells generated from it were meant to die off as these cells are not well
retained in the SVZ or structures nearby such as the striatum (Morshead & van
der Kooy 1992). One important study showed that cells labeled by the
proliferation marker BrdU do not remain in the SVZ for an extended amount of
time, but instead of dying, they migrate to the OB and mature into neurons (Lois
& Alvarez-Buylla 1994). Additional work since then has clarified the SVZ to OB
migration process (figure 2).
It has been estimated that tens of thousands of interneurons are replaced
daily by this neurogenesis mechanism (Chang et al 2016). The SVZ is the thin layer
of cells covering the lateral ventricles; newborn cells in the SVZ migrate toward
the OB via a well-characterized path called the rostral migratory stream (RMS).
The SVZ is considered a niche, a unique environment that is home to quiescent,
neural stem cells (referred to as type B cells) with astrocytic features. Type B
neural stem cells become activated and divide in a process called asymmetric
division to generate two daughter cells. One daughter is another type B stem cell
and another is a transit-amplifying progenitor called type C cell. Type C cells can
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divide many rounds by symmetric division to give rise to a much larger population
of another cell type called neuroblasts (type A cells). Type A cells are committed
to a neuronal lineage but are not terminally differentiated. Neuroblasts migrate
through the RMS toward the OB in a process called tangential migration. The
distinct migration path of neuroblasts is well characterized, and is termed “chain
migration” because chains of neuroblasts in close contact move forward by
contacting each other in a chain like fashion (Lois et al 1996). Once neuroblasts
reach the OB core, they migrate radially into the OB parenchyma. Here, they
finish their maturation and terminally differentiate into GABAergic and
periglomerular interneurons. A very small percentage also become glutamatergic
juxtaglomerular cells (Lazarini & Lledo 2011).Besides producing new neurons, SVZ
neurogenesis can generate new oligodendrocytes and astrocytes. New
oligodendrocytes migrate dorsally and are found in the corpus callosum (Menn et
al 2006). The newly generated astrocytes have been found to migrate toward
injured areas of the brain (Benner et al 2013). SVZ neurogenesis has also been
detected in the adult human brain and other primates; however, its purpose is
less well known (Chang et al 2016).
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SVZ Neurogenesis and Its Contribution to OB Neuro-circuitry

Figure 2: subventricular zone (SVZ) neurogenesis and olfactory bulb (OB)
migration, differentiation and maturation. A Sagittal view of the rat brain showing
the connection between the SVZ, rostral migratory stream (RMS) and OB. B
Enlargement of the boxed area in part A, showing the different neuronal layers of
the OB. The neuroblasts leave the RMS in single cell fashion and differentiate into
granule cells (GC) and periglomerular cells (PGC). C Depiction of the chain
migration of type A cells also known as neuroblasts. D Type A cells differentiate
into either GC or PCG; each can be distinguished by a unique combination of
cellular markers and their neurotransmitter phenotype. Adapted from (Lim &
Alvarez-Buylla 2016).
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Migration is an important component of neurogenesis during development
and the adult. Migration allows cells to move from the place where they were
born to their eventual destinations. Along their migratory path, they encounter
different interactions such as cell-to-cell, trophic factors and extra-cellular matrix;
these interactions play a large role in the development of new neural cells. There
are three distinct migratory modes that can be seen during adult neurogenesis,
i.e., tangential, radial, and chain migration.
Chain migration is the unique migratory pattern seen in the RMS. Type A
cells produced in the SVZ traverse the millimeters-long RMS pathway that
connects the SVZ and the OB. These migratory cells use each other as tracks to
move forward (Lois & Alvarez-Buylla 1994). This pattern of migration is referred to
as homotypic because the type A cells slide along each other. The leading cell will
extend a growth cone that serves as a track for the few following cells
(Kempermann 2011). Interestingly, in rodent, the RMS is ensheathed in a tubelike structure made up of glial cells; however, functionally, little is known about
this glial structure (Gritti et al 2002). One study disrupted this glial structure by
manipulating the Beta1 Integrin level and found that chain migration still
occurred; however, type A cells moved away from the stream prematurely
(Belvindrah et al 2007). In humans, chain migration and the existence of the RMS
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had not been extensively confirmed due to the difficulty in observing this
anatomical feature. Human neuroblasts have been seen migrating along the
obliterated olfactory ventricle in a manner different than that of rodents and
without the characteristic cluster of migrating cells (Curtis et al 2007).
Radial migration is seen both in developing CNS as well as in the adult
brain. During development, radial migration is seen when new neurons from the
ventricular plate migrate out to their terminal location in the different cortical
layers. Radial migration during the developmental phase relies on radial glia as
the guiding tracks (Poluch & Juliano 2007). In adult neurogenesis, once type A
cells reach the core of the olfactory bulb, these immature neurons switch their
mode of migration and start moving radially toward the granular and
periglomerular layers. In the OB, blood vessels serve as radial scaffold for the
migration of type A cells (Bovetti et al 2007). On the other hand, tangential
migration is the process in which interneurons move in parallel direction to the
plane of the ventricular plate; this migratory process is independent of radial glia.
In adult rodents, it has been shown that GABAergic neurons are generated in the
SVZ and migrate tangentially toward key structures of the brain such as the
cortex, striatum and nucleus accumbens (Inta et al 2008).
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SGZ Neurogenesis
The hippocampus is another brain structure that was found to produce new
brain cells. Specifically, the subgranular zone (SGZ) of the dentate gyrus, which is
at the junction of the hilus and the granule cell layer, is the niche for neural stem
cells. Neural stem cells in the SGZ have a different cellular organization compared
to their SVZ equivalents. SGZ stem cells are not located next to a ventricle and are
surrounded by other neurons (Kempermann 2011). Interestingly, SGZ stem cells
have long processes that extend to the granular and molecular layers of the
hippocampus. These quiescent stem cells in the SGZ are called type 1 cells, which
in turn divide asymmetrically to produce progenitors called type 2a and 2b cells.
Type 2a and 2b progenitors divide symmetrically to produce neuroblasts which
eventually mature and terminally differentiate into glutamatergic dentate granule
cells (figure 3). Newborn hippocampal neurons are hyperexcitable during the
critical maturation period of 3-6 weeks after their birth. These new cells receive
excitatory glutamatergic inputs from the entorhinal cortex, however, without
having inhibitory GABAergic inputs, they have a low threshold for the induction of
long-term potentiation (LTP).

51

Hippocampal Neurogenesis

Figure 3: Neurogenesis, differentiation and maturation in the dentate gyrus of the
hippocampus. A. Sagittal view of the rodent brain (left) showing the relative
location of the dentate gyrus of the hippocampus (HP) to that of the SVZ and
lateral ventricle (LV) and the olfactory bulb (OB). Right: enlargement of
hippocampus showing cellular connections between the sub-structures of the
hippocampus. Perforant path compose of entorhinal cortex input signal by
forming synapse with dentate granule cells, which are continually generated by
neurogenesis. Granule cells form synapses with pyramidal cells of CA3, and these
cells in turn form synapses with CA1 neurons. B. Summary of neurogenesis in the
hippocampus. Radial glia-like (RGL) neural stem cells divide to become
intermediate progenitor cells (IPCs), which in turn proliferate into neuroblasts.
These new neuroblasts undergo several immature stages to finally become
mature granule cells. Adapted from (Christian et al 2014).
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Molecular Regulators of Neurogenesis
Neural stem cells and progenitors in the SVZ and dentate gyrus are exposed
to complex microenvironments composed of local cells and diffusible molecules.
Many of the common neurotransmitters in the brains have regulatory functions in
neurogenesis. For instance, NMDA receptor dependent activity is inversely
correlated with hippocampal proliferation (Zhao et al 2008). Glutamate, the
predominant excitatory neurotransmitter in the CNS is the main ligand for NMDA
receptors. Furthermore, an in vitro study using hippocampal stem/progenitor cells
showed glutamate increasing neuronal differentiation (Deisseroth et al 2004).
Similarly, the neurotransmitter GABA binds to type 2 progenitor cells in the
hippocampus leading to calcium influx and depolarization and subsequent
increased expression of NeuroD, a neuronal differentiation factor (Tozuka et al
2005).
The growth factor family of molecules also potently affects neurogenesis.
In vivo studies demonstrated that both epidermal growth factor (EGF) and
fibroblast growth factor 2 (FGF2) increase SVZ stem cell proliferation (Kuhn et al
1997). Additionally, FGF2 administration leads to increased incorporation of new
neurons to the olfactory bulb. FGF2 signaling might also play a crucial role in
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hippocampal neurogenesis as one study showed that by deleting its receptor
fgfr1, SGZ neurogenesis was decreased (Zhao et al 2007). Another key regulator of
neurogenesis is brain-derived neurotrophic factor (BDNF). Transgenic animals
lacking BDNF receptor p75 have smaller olfactory bulbs and impaired SVZ
neurogenesis. Interestingly, BDNF appears to mediate antidepressant-induced
increase in hippocampal neurogenesis. One study showed that using transgenic
mice with deficits in TrkB signaling (the main receptor for BDNF), antidepressant
treatment failed to increase SGZ cell proliferation (Duman & Monteggia 2006).
ROS have traditionally been thought to be detrimental to cellular activities.
ROS accumulation is a result of oxidative stress and is a contributor to many
diseases and neurodegeneration in the brain. The effect of ROS on stem cells is
intriguing; for instance, hematopoietic stem cells (HSCs) maintain a low
endogenous level of ROS, which is critical for the maintenance of quiescence. This
is important to prevent the exhaustion of the available pool of stem/progenitor
cells (Jang & Sharkis 2007). Intracellular ROS had emerged to be a critical second
messenger in a tightly controlled signal transduction system to control cellular
proliferation (Kwon et al 2004). Endogenous ROS levels are controlled by
mitochondrial activity and several NADPH oxidase (NOX) enzymes (Lambeth et al
2008). In contrast to the HSCs, neural stem cells (NSCs) are dependent on the ROS
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as the mediator of the proliferative response (Figure 4). One important study
found higher ROS levels in the neural stem/progenitor cells in the SVZ (Le Belle et
al 2011). Additionally, when ROS was artificially increased by the addition of nontoxic concentration of H2O2 in vitro, SVZ stem cell proliferation significantly
increased. This same study also showed that NOX2 mutant mice had impaired SVZ
proliferation and smaller olfactory bulbs (Le Belle et al 2011).

Figure 4: Reactive Oxygen Species (ROS) regulation and its role in SVZ
neurogenesis. Adapted from (Le Belle et al 2011).
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Systemic Regulators of Neurogenesis
It is well known that aging is associated with a progressive decrease in
cognitive functions such as memory formation. Furthermore, strong evidence
exists in animal models for the decline in total neurogenesis in aged animals (Zhao
et al 2008). The hippocampus is the brain structure most often associated with
memory formation. In aged animals, both hippocampal volume and the level of
neurogenesis significantly decrease (Driscoll et al 2006). Other reports utilizing
transgenic mice demonstrated that in the SGZ of aged animals, there were
significant reductions in both the number of stem/progenitor cells and the
proliferative rate of those cells (Walter et al 2011). However, cognitive
impairment in the aged animals did not necessarily correlate with decreased
neurogenesis. One study used the MWM to demonstrate that in aged rats,
animals with impaired learning ability have higher proliferative rate in the SGZ
compared to a similarly aged group with intact learning ability (Bizon et al 2004).
Additionally, aging also affects the SVZ-OB area and its function in both humans
and experimental animal models. For instance, in humans, olfactory
discrimination abilities decrease with age (Kaneda et al 2000). One important
study using a mice model of aging found that aged animals exhibit decreased SVZ
proliferation and less OB new interneurons compared to younger mice (Enwere et
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al 2004). Additionally, the aged mice performed the same as young mice when
discriminating two discrete odors; but performed significantly worse at
discriminating similar odors. This finding indicates that SVZ-OB neurogenesis is
important in fine olfactory discrimination tasks. This same group also found that
the OB of aged mice expressed less epidermal growth factor (EGF) and its
corresponding receptor (EGFR).
Stress is another potent negative regulator of neurogenesis. Increased
stress leads to decreased cell proliferation in the dentate gyrus of the
hippocampus. This phenomenon had been reported in various species including
mouse, rat, tree shrew and marmoset (Mirescu & Gould 2006). Various stressors
were used in these animal models to demonstrate this effect including
subordination, resident-intruder, foot-shock, restraint, isolation, cold
immobilization, cold swim and predator odor (Gould et al 1997, Gould et al 1998,
Malberg & Duman 2003, Pham et al 2003). Furthermore, both acute and chronic
stressors cause decreased hippocampal neurogenesis (Mirescu & Gould 2006).
The cause for decreased hippocampal neurogenesis following stress is linked to
stress hormones like glucocorticoids. Glucocorticoids directly regulate
hippocampal neurogenesis. For instance, the cells of the hippocampus express
adrenal steroid receptors. Furthermore, modulating circulating levels of these

57

stress hormones changes hippocampus structure and functions (McEwen 1999).
Studies in which either the adrenal gland was removed or pharmacological
methods were used to inhibit the HPA axis (CRF-1 and V1b receptor antagonists)
showed an increase in hippocampal neurogenesis (Cameron & McKay 1999);
(Alonso et al 2004). In contrast, administering exogenous corticosterone to
postnatal and adult rodents leads to an opposite decrease in hippocampal
neurogenesis (Cameron & Gould 1994, Gould et al 1991). Taken together, these
findings indicate that glucocorticoids are the major mediator of stress-induced
effects on hippocampal neurogenesis.
In contrast to age and stress as two of the most characterized negative
regulators of neurogenesis, various environmental factors contribute positively to
neurogenesis. For instance, voluntary running had been shown to promote SGZ
cell proliferation (Kee et al 2007). Exposure to an enriched environment was
shown to increase new hippocampal neuron survival (Olson et al 2006).
Importantly, both voluntary exercise and environmental enrichment lead to an
increase in performance of animals in the MWM (Zhao et al 2008). One study
used a transgenic strain of mice lacking presenilin-1, which is a protein critical to
the memory function of the hippocampus and showed that environmental
enrichment did not elicit a response in neurogenesis in these animals (Feng et al
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2001). Taken together, these studies demonstrate the hippocampal functional
implications of increased neurogenesis caused by positive environmental
regulators.
Neural activity has also been shown to positively regulate neurogenesis.
The relationship between learning and SGZ neurogenesis is complex with
specificity toward experimental tasks, phases of learning and SGZ
stem/progenitor cell types (Zhao et al 2008). The enhanced survival of new
hippocampal neurons is only seen in learning tasks that are specifically dependent
on the hippocampus. For instance, trace eyeblink conditioning and the Morris
water maze lead to higher survival of newborn SGZ neurons while the active
shock avoidance and delayed eyeblink conditioning did not (Leuner et al 2006).
Hippocampal learning does not simply lead to a general increase in SGZ
proliferation and survival. One interesting study showed that training in the
MWM increased apoptosis of the early proliferating cells and that blocking this
apoptosis event led to worse subsequent performance (Dupret et al 2007).
Additionally, learning tasks such as the MWM can be broken down into specific
stages, such as the early phase where rapid improvement of performance is seen
and late asymptotic phase. Each of these phases affects hippocampal
neurogenesis differently. No SGZ cell proliferation is observed during the early
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phase while during the late asymptotic phase, increased hippocampal cell
proliferation is observed (Döbrössy et al 2003). These findings illustrate the
complexity and specificity of learning-induced increases in hippocampal
neurogenesis and suggest the functional importance of integration of only a
subset of newborn neurons.
Functions of SVZ and SGZ Neurogenesis
The field of neurogenesis is still in its infancy; however, the roles of new
neurons that are produced by neurogenesis are starting to be clarified by studies.
While neurogenesis is not required for survival in laboratory animals, functional
deficits are evident using sensitive behavioral tasks. For instance, new neurons
that are produced in the SVZ and migrate to the OB integrate into the existing
interneuron circuits and significantly contribute to the network activity. The
olfactory system processes odorant signals from the environment. Specifically,
odorant molecules enter the nasal cavity and bind to olfactory receptors, which
are expressed by olfactory sensory neurons (OSNs). These sensory neurons have
axons that pass through the cribiform plate and innervate the OB. Mitral and
tufted cells are the main projection neurons that receive the signals from OSNs
and send them to higher olfaction processing centers (Munger et al 2009).
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Periglomerular and granule cells are GABAergic inhibitory neurons that are being
continually generated by neurogenesis in the SVZ. These cells make contact with
OSN axon terminals and the dendrites of mitral and tufted cells and modulate the
incoming olfactory signals. In effect, these new inhibitory interneurons play
important roles in fine tuning the olfaction signals (Lazarini & Lledo 2011). These
new neurons are not necessary for the detection or discrimination of odorants,
but seem to have some roles in the cognitive processing of odorant context. An
example of this process is learning to discriminate two or more similar odors
(Moreno et al 2009). Intriguingly, when OB neurogenesis is prevented, which
leads to the depletion of OB interneurons, no sensory deficits were observed with
tasks such as smell discrimination (Imayoshi et al 2008). Yet, similar irradiations of
the OB resulted in significant impairments in olfactory fear conditioning (Lazarini
et al 2009).
In the hippocampus, newly produced granule neurons participate in a
similar process that is called pattern separation. This is when similar inputs are
differentiated and processed as distinct conditions (Clelland et al 2009). Pattern
separation manifests as the ability to discriminate subtle differences in spatial
patterns. This can be traditionally assessed by the spatial memory task, the
MWM, in which animals have to use environmental visual cues to find the hidden
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platform in a pool of water (Garthe & Kempermann 2013). Studies that ablate
hippocampal neurogenesis consistently resulted in deficits in the MWM
performance. In contrast, studies that use methods to stimulate hippocampal
neurogenesis lead to improvement in the MWM task (Lacar et al 2014, Sahay et al
2011a). These studies demonstrate that hippocampal neurogenesis in rodents is
important for acquisition of the platform location, probe trial performance (when
the platform is removed to access the length of time animals are in the goal
quadrant), and reversal (when the platform is move to a random new location
and the animals have to re-learn) (Garthe & Kempermann 2013).
While the functional relevance of adult neurogenesis in rodents has been
well established, their roles in adult humans are less well understood. However,
adult neurogenesis is implicated in a number of diseases such as epilepsy and
major depression, (Braun & Jessberger 2014). A decrease in adult hippocampal
neurogenesis does not contribute to the development of depression. However,
hippocampal neurogenesis is necessary for the efficacy of antidepressants (Sahay
& Hen 2007). On the other hand, aberrant hippocampal neurogenesis has been
implicated in epileptogenesis (Parent & Murphy 2008). New hippocampal neurons
after either seizure or traumatic brain injury can form abnormal networks that
can play a role in future propagation of seizure activity. Furthermore, striatal
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interneurons are being generated throughout the human adult lifetime by adult
neurogenesis. This same population of interneurons has been found to be
depleted in Huntington’s disease (HD) patients raising the possibility that the lack
of adult neurogenesis might contribute to the HD disease state (Jessberger &
Gage 2014).
SVZ Neurogenesis in TBI
Mechanical forces involved in primary TBI can affect the SVZ directly and
therefore affect neurogenesis. For instance, cranial compressive force can tear
the lateral ventricle lining and increase intracranial pressure. Hemorrhages
(epidural, intracranial, extradural) can cause a persistent increase in intracranial
pressure and increase in lateral ventricular pressure. Hemorrhages can lead to
obstructive hyrocephalus and lead to lateral ventricular hydrostatic pressure.
Hydrocephalus has been shown to cause mechanical damage to the lateral
ventricular wall (Bruni et al 1985, Sarnat 1995). Additionally, brain edema, which
is part of the mid-term secondary injury process, leads to elevated intracranial
pressure. In contrast, cortical lesions with extensive brain matter loss lead to
enlarged ventricle volume (Reider-Groswasser et al 2002). These are the possible
mechanical stresses that can affect the SVZ stem cell environment.

63

The mechanism for stem cell responses to mechanical forces has been described:
for instance β-catenin/Wnt signaling : β-catenin can translocate to the nucleus in
response to increased mechanical force. In the nucleus, β-catenin inhibits cell
cycle exit and this leads to an increase in proliferation (Chenn & Walsh 2002).
Ependymal cells are ciliated cells lining the lateral ventricle wall and are the
first part of the SVZ structure. These ciliated cells affect SVZ fluid dynamics and
form a barrier that separates the fluid of the lateral ventricle and the SVZ cells by
tight junctions with each other (Mitro & Palkovits 1981). It is thought that TBI
affects the strength of these ependymal tight junctions in addition to other
extracellular interactions, which can lead to enlarged ventricles. Ventricular
enlargement can be modeled in the rat by kaolin administration, which leads to
communicating hydrocephalus. This model demonstrated that there is a transient
increase in the number of SVZ Nestin+ cells, which are mature neurons, in
communicating hydrocephalus.
There is some evidence to suggest that more neuroblasts survive after TBI
compared to normal animals. For instance, in a mouse transgenic model of TBI
using CCI, SVZ proliferative cells were labeled by yellow fluorescence protein
(YFP). After a period of 6 weeks post-TBI, the number of YFP+/DCX+ double
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positive cells was increased in the dorsolateral SVZ but few were found in the TBI
lesion area (Mierzwa et al 2014). Another separate study found very few mature
neurons in the perilesional area 28 days after injury (Goodus et al 2014).
Furthermore, the SVZ is a distinct niche compared to areas that the neuroblast
migrate to such as the corpus callosum or the cortex; and these different niches
affect differentiation of newly proliferated cells differently. For instance, one
interesting study found that newly generated SVZ cells that migrated to the
corpus callosum after TBI became oligodendrocytes. In contrast, those that
migrated to the perilesional area became astrocytes (Goings et al 2004). Another
study found that most BrdU positive cells in the perilesional area were either
positive for Iba1 or GFAP but not NeuN (Radomski et al 2013). Overall, there is
strong evidence for TBI increasing the survival and migration of SVZ derived cells;
yet evidence for the differentiation of these new SVZ-derived cells into
functionally relevant new cortical neurons is limited.
Detection of Neurogenesis by Measuring Cell Proliferation
Cell proliferation is a critical parameter of neurogenesis: Cell proliferation
gives rise to new cells in the SVZ because it contains cells with proliferative
capacity (stem cells). Cell proliferation is most commonly assessed using 5-Bromo-
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2”-deoxyuridine (BrdU) labeling. BrdU is injected into an animal or introduced into
the media of an in vitro system, and cells that are actively dividing will take up this
DNA nucleotide analog and incorporate it into the genome. Monoclonal
antibodies against BrdU are used to detect it in cells. BrdU labeling detects cells
that are in the S-phase of the cell cycle; however, there are some thoughts that
reporting a pure number of BrdU+ cell is less useful than measuring what is called
the “labeling index” which is basically the percentage of cells that are BrdU+
(Chang et al 2016). In addition to using BrdU to detect the population of cells that
have undergone proliferation, intrinsic markers of the cell cycle can also be used.
For instance, proliferative cell nuclear antigen (PCNA) and Ki67 are the two most
widely used markers.
There are some interesting differences in how the SVZ of rat and mouse
response to a cortical injury with the caveat that these results are from multiple
labs using different models of TBI. Generally, proliferation increases after TBI, but
only transiently before going back to baseline. There are several studies in the
mouse that indicate that proliferation decreases after TBI (Goings et al 2002,
Jankovski et al 1998). In the rat, multiple studies looking at proliferation at
different time points after TBI seem to indicate that there are four distinct phases
in the SVZ proliferative response (Chang et al 2016). During the first five days,
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proliferation appears to be unchanged; between 5 days and seven days,
proliferation peaks with about 100% increase over baseline; from the peak at 7
days, proliferation remains high but slowly declines and comes back to baseline at
4 weeks after TBI (Bye et al 2011). However, by 8 weeks after TBI, baseline
proliferation is decreased by about 50% (Acosta et al 2013).
SVZ Proliferation in Humans After TBI
There is considerable evidence for SVZ proliferation in humans. For
instance, children two years old and younger have a high level of constitutive SVZ
proliferation. However, in adults, evidence has not been as strong. One study
found that after 18 months of age, proliferation along the RMS and SVZ are not
detectable (Sanai et al 2011). On the contrary, another study found that there are
migrating doublecortin positive cells (DCX+) in the RMS and olfactory bulb in
adults (Wang et al 2011). Furthermore, using a novel technique of carbon (14C)
dating, proliferative SVZ and striatal neurogenesis was detected in adult brains
(Bergmann et al 2012, Ernst et al 2014). 14C is an isotope of carbon that is
elevated following terrestrial nuclear bomb testing. The use of this carbon dating
technique is very useful in birth dating neural cells; however, it requires highly
specialized equipment. Other alternative techniques that had recently been used
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to investigate human neurogenesis are non-invasive magnetic resonance imaging
(MRI) and positron emission tomography (PET) (Jessberger & Gage 2014).
However, these imaging techniques at this point still lack specificity and
resolution to accurately detect neurogenesis in humans.
Following TBI, one post-mortem study looked at brain tissue of a group of
children; 6 had TBI and 7 were non-TBI controls. They detected no differences in
the number of DCX+ cells (Taylor et al 2013). On the contrary, a separate group
found that adult patients following TBI expressed a higher number of cortical
DCX+, PSA-NCAM+ and SOX2+ cells, all of which are markers indicative of
neurogenesis (Zheng et al 2013). Overall, more complete human studies are
needed to definitively evaluate if TBI has an effect on SVZ proliferation; for
instance, better use of markers for proliferation, better control of TBI type, age,
and timing are needed for conclusive results.
It had been thought that for the therapeutic potential of stem cells to be
fully realized, the newly produced cells must migrate from the site that they are
produced (in this case the SVZ) to the lesion area. In adult rodents, newly
produced immature neurons, i.e., neuroblasts, migrate from the SVZ to the OB
along the RMS in strings in chain migration, which is in part assisted by a network
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of astrocytes (Jankovski & Sotelo 1996, Lois et al 1996). In the event of a CNS
injury, the stream of migrating neuroblasts are induced to migrate out in both
chains and as individual cells. Diffusible protein signaling is thought to be playing a
role in attracting neuroblast migration toward the lesion area (chemoattractants).
Astrocytes in the lesion area secrete SDF-1, which has been shown to increase
mobility of neuroblasts (Kokovay et al 2010). In the mouse, OB transection
experiments in which the RMS is cut has shown that neuroblasts accumulate
posterior to the cut and that these cells migrate toward the cortical lesion and
striatum (Jankovski et al 1998). It was found that in response to cortical TBI,
neuroblasts migrate out of the RMS in chain formation and enter into the corpus
callosum; however, when they go into the cortex, they migrate as individual cells
which suggest there are multiple mechanisms of migration of neuroblasts after
injury (Kempermann 2011). The evidence for neuroblast migration toward the
injury site in humans is less convincing. One post-mortem study looking at brain
tissue from children less than 10 years old detected the presence of DCX+ cells
that had the morphology of migratory cells; these DCX+ cells were negative for
astrocyte, microglia or macrophage markers (Taylor et al 2013).
The limited endogenous stem cell response means that finding a
pharmacological means of increasing this intrinsic stem cell response might be
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useful in treating TBI. To this end, there are many potential therapies that have
shown good promise in experimental models. A study using activated protein C
delivered intraperitoneally to mice increased post-TBI neuroblast proliferation
and migration to the perilesional area (Petraglia et al 2010). Furthermore,
administration of colony-stimulating factor (GCSF) after TBI was shown to lead to
increased DCX+ cells in the SVZ (Yang et al 2010). One group showed that either
GCSF and/or human umbilical cord blood cell (hUBC) significantly increased SVZ
and hippocampal DCX+ cells 8 weeks after TBI (Acosta et al 2014). Infusion of
growth factors was shown to increase some aspect of SVZ neurogenesis and could
theoretically be a potential treatment for TBI. For instance, administration of
BDNF and its molecular mimetic resulted in SVZ derived cells migrating toward
adjacent nuclei (Benraiss 2001). EGF and FGF2 administration led to higher SVZ
proliferation (Kuhn et al 1997). TGF-a administration resulted in higher striatal
accumulation of SVZ derived cells (Craig et al 1996). Extra-cellular matrix (ECM)
molecules and cell surface protein can also play a role in neurogenesis. Matrix
metalloproteinase (MMP) regulates ECM molecules by degrading them and also
plays a role in regulating neurogenesis. The cell surface proteins EphrinB3 and
EphB3 can control SVZ neurogenesis via a p53 dependent mechanism (Theus et al
2010). While these experimental means to increase neurogenesis have yielded
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interesting cellular responses, further work needs to be done to evaluate their
functional relevance and to identify any negative outcomes. Overall, in order to
identify worthwhile therapies for use in the clinics, significant improvements in
the standardization of animal models for TBI and the behavioral tasks used to
evaluate these animals are needed.

CHAPTER THREE
METHODS
Animal Subjects
Male Sprague Dawley rats (Harlan, IN), 2 month old at the beginning of the
experiments, were used in our study (total animal number:76) (Table 3 and 4).
Rats were housed as a pair in each cage in a fully accredited animal care facility
with a 12-hour light/dark cycle. Food and water was available ad libitum.
Experiments were approved by the Hines VA Institutional Animal Care and Use
Committee. All animals were number coded and investigators were blinded to
the animal treatment groups.
Alcohol Administration
Rats were administered three consecutive doses of alcohol by gastric
gavage at a dose of (3g/kg, i.g. of 40% alcohol) once per day for three days
(Figures 5 and 6). A curved stainless steel gavage needle with a smooth rounded
ball head was used along with a 5cc syringe to administer the alcohol (Oregon
State University,Laboratory Animal Resources Center, 2011). Additionally, the
gavaging needle was lubricated with food-safe lubricant; all animals tolerated the
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gavage procedure with no adverse effects. Control animals received an equal
volume of water, given using an identical dosing schedule. This alcohol dose leads
to blood alcohol levels typical of a TBI patient entering the emergency room
(150mg/dl) (Bombardier & Thurber 1998) and was well tolerated by these rats
which lead to no adverse weight loss during the three days administration
window. Furthermore, this dosing regimen has been adapted from one previously
used to mimic binge drinking (Przybycien-Szymanska et al 2010). One hour after
the last gavage administration, animals were either subjected to a moderate brain
injury using the controlled cortical impact model (CCI) of TBI or given a sham
surgery (Figures 5 and 6).
Blood Alcohol Level Quantification
Approximately 250ul to 500ul of blood was drawn for the tail vein of each
rat immediately following the TBI surgery. Blood was then allowed to clot on ice
for five minutes and centrifuged, to separate the serum. Alcohol concentration
was measured using alcohol reagent set (Pointe Scientific, Canton MI, USA). The
alcohol reagent set relies on an enzymatic method to detect ethyl alcohol:
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Table 3. Experimental Groups for Aim 1
Group

Alcohol

TBI

24
hrs

1 week

1

-

-

6

6

2

-

+

6

7

3
4

+
+
Subtotal

+

6

Table 4. Experimental Groups for Aim 2
Group

Alcohol

TBI

6 weeks

1

-

-

6

2

-

+

7

3

+

-

6

4

+

+

7

6

6

7

24

26
Total

Total

26

50

Table 3 and 4: Animal numbers and groups for Aim 1 and Aim 2 respectively.
Animals were randomly assigned to each of the 4 experimental groups, either
with alcohol or vehicle and TBI or sham.
Alcohol dehydrogenase (ADH) catalyzes the reaction of ethanol to acetaldehyde
with the concomitant reduction of NAD+ to NADH; this leads to a change in
absorbance at 340 nm which is directly proportional to the ethanol concentration
in the sample. The serum samples were de-proteinized using 6.25%
trichloroacetic acid; 0.9% sodium chloride was used as the non-serum blank.
Samples were loaded onto 96 well plates at a sample/reagent ratio of 1:201,
incubated at 30°C for 5 minutes, and the absorbance was read at 30°C. A
standard curve was generated for each assay run from the known ethanol
samples. Sample measurements were done in duplicate and the values averaged
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for each animal. Known high and low alcohol controls were always run along with
unknown samples and the resultant alcohol concentration values for the controls
were always within acceptable range (+/- 5%).

Figure 5: Experimental design for Aim 1. Rats experienced 3 consecutive daily
doses of alcohol binge. One hour after the last alcohol dose, animals undergo TBI
surgery. Animals sacrificed at 24 hours after TBI received only 1 dose of BrdU
injection by i.p at the time of TBI. Animals sacrificed at 7 days received 7
consecutive daily doses of BrdU.
TBI

BrdU Injections
(100mg/kg/day,
7days)

Lesion Analysis
Immunohistochemistry
3 Days Alcohol Binge
(3g/kg/day)

Euthanize at 6
weeks post
TBI

Stereology

Figure 6: Experimental design for Aim 2. Rats experienced binge alcohol, TBI and
BrdU injections identically to those in Aim 1. Animals survived for 6 weeks
following TBI.
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TBI Model
All rats were anesthetized using 75mg/ml of isoflurane delivered as an
inhalant with 5% oxygen. The TBI was delivered using a double acting magnetic
piston mounted on a stereotaxic crossbar, angled for cortical impact (diameter: 3
millimeters, velocity: 2.5 meters/second, depth: 2 millimeters, dwell time: 250
milliseconds). Animals were secured in a stereotaxic frame and a midline incision
was made and the skin was pulled back. The analgesic buprenorphine was
administered locally near the skin incision (0.1cc). Using a trephine, a disc of skull
bone was removed above the forelimb area of the sensorimotor cortex (1
millimeter anterior, 1.5 millimeter lateral from bregma) on the right hemisphere.
Saline solution (0.9%) was used during the trephine process to minimize heat.
Before the impactor was placed in position, the dura layer covering the brain was
carefully removed. This impact resulted in a reproducible lesion, typified by both
focal and diffuse brain damage. Sham animals were treated identically
(anesthetized, skin incision, etc), apart from the piston. The CCI model has the
advantage that it allows the experimenter to control precisely the physical/kinetic
variables of the injury (velocity, dwell-time, diameter, etc). In our model, this
injury leads to prolonged deficit on the skilled forelimb-reaching task. Most
importantly, the CCI model is clinically relevant, leading to the histological
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sequelae often seen in humans after TBI: epidural and subdural hematoma as well
as intraparenchymal petechial hemorrhages. Following the surgery, rats were
closely monitored for complications; rats were able to ambulate and eat normally
in less than three hours post injury.
Bromodeoxyuridine (BrdU) Administration
Bromodeoxyuridine (BrdU) is an analog of the nucleoside thymidine that
can be incorporated into the DNA during DNA synthesis. During cell division,
extensive DNA synthesis occurs in the genome prior to physical cell division thus
BrdU incorporation is a stable marker for proliferation (Taupin 2007). Commonly,
BrdU is administered through intraperitoneal (i.p.) injection, and it is estimated
that BrdU is available for labeling proliferating cells in the brain for approximately
two hours after administration (Taupin 2007). BrdU can be detected histologically
using monoclonal antibodies and combined with labeling various cell phenotype
markers; this essentially allows for the birthdating and cell-type determination of
newborn cells.
There is a dose-dependent effect of BrdU administration on the number of
labeled cells in the proliferative brain regions saturating at around 200mg/kg. This
dose has been found to maximally label proliferating cells in the dentate gyrus
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after stimulating proliferation with exercise (Cameron & Mckay 2001, Eadie et al
2005). For long-term assessment of newborn cell phenotypes, it is necessary to
administer multiple doses of BrdU spaced further apart to mitigate the effects of
BrdU dilution over successive cell divisions.
In this dissertation, two separate BrdU injection paradigms were used. In
both cases, BrdU was prepared at 20mg/mL in sterile saline. The solution was
warmed in a water bath and repeatedly vortex-mixed until dissolved and then
sterile-filtered through a 0.22 um syringe filter. To measure short-term cellular
proliferation, a single injection of BrdU at 100mg/kg body weight (i.p.) was
injected immediately after TBI followed by sacrifice 24 hours after. For mid-term
determination of cell proliferation and long-term determination of newborn cell
phenotypes, BrdU was injected at 100mg/kg (i.p.) starting immediately following
TBI and continuing once a day for the next six days. Rats were anesthetized with
isoflurane during BrdU injection to minimize discomfort.
BrdU labeling is advantageous compared to staining for endogenous
proliferation markers such as Ki67 or PCNA (Proliferating Cell Nuclear Antigen)
because of its short half-life; this property of BrdU essentially allows us to birth-
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date the new cells. BrdU was injected after TBI, labeling only the proliferative
response after TBI.
Perfusion, Tissue Processing, and Histology
At various time points, rats were overdosed with Euthasol
(phenytoin/pentobarbital; 390 mg/kg i.p.) and transcardially perfused with cold
heparinized saline followed by 4% paraformaldehyde (PFA). Brains were extracted
and post-fixed overnight at 4°C in 4%PFA, then cryoprotected in 30% sucrose in
phosphate buffer pH 7.4 until sinking. Brains are then frozen in Optimal Cutting
Temperature Compound (OCT) for cryosectioning. Sections (40 μm) were cut on a
cryostat and stored in ethylene glycol-based antifreeze cryoprotectant at -20°C
until use. BrdU requires an antigen retrieval procedure to be identified
immunohistochemically. Our method was adapted from (Tang et al 2007), where
tissue sections were subjected to high heat (99-100° C) sodium citrate solution for
10-15 min. This method was preferable to hydrochloric acid-based procedures
since this severely weakens subsequent DNA staining, such as with DAPI or
Hoechst. However, incubation of free-floating sections in boiling sodium citrate
leads to excessive wrinkling of the tissue that impairs downstream processing
steps. Therefore, we adapted a staining method where the tissue sections were
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extensively washed in phosphate buffer pH 7.4, mounted on plus-charged slides,
and then allowed to dry overnight at room temperature. The following day, the
slides were incubated in 99-100° 10 mM sodium citrate pH 6, which had been
placed in a container in a boiling water basin, for 10 minutes. The slides were then
removed and immediately immersed in room temperature phosphate buffer pH
7.4. From there, the tissue sections were carefully removed from the slides using
a razor blade and rinsed in phosphate buffer. We found that using this strategy,
tissue wrinkling was nearly eliminated, while still allowing us to perform freefloating tissue staining (which allows for better antibody penetration) on thick
tissue sections (which are required for the optical fractionator stereology probe).
This procedure led to bright BrdU staining that was compatible with general
DNA labeling using DAPI, as described by Tang and colleagues (Tang et al 2007).
However, we experienced very high white matter nonspecific fluorescence, as if
the white matter had become extremely “sticky” to antibodies. This was traced to
the use of high concentrations of the detergent Triton X100 in the incubation
buffers. Switching to Tween-20 greatly reduced the background fluorescence and
was therefore used in all steps after high heat antigen retrieval.
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Immunostaining was performed by diluting primary antibodies in
phosphate- buffered saline (PBS) pH 7.4 plus 0.2% Tween-20 (when high heat
antigen retrieval was used) or 0.3% Triton-X100 (when no antigen retrieval was
used). Tissue sections were then incubated in primary antibody solution overnight
at 4° C with gentle agitation. The following day, the tissue sections were
extensively washed in PBS/0.2% Tween 20 (for high heat antigen retrieval) or
phosphate buffer pH 7.4 (when antigen retrieval was not performed). The
sections were then incubated in fluorophore- or biotin-conjugated secondary
antibodies in the same dilution buffers listed above for 2 hours at room
temperature with shaking, and then washed. For fluorescent imaging, nuclei were
counterstained with DAPI, then mounted on gelatin-subbed slides and
coverslipped with Fluoromount G anti-fade mounting media. For signal detection
with the chromogenic substrate diaminobenzidine (DAB), tissue sections were
incubated in avidin-biotin- peroxidase complex (Vector Laboratories, 1 drop
component A plus 1 drop component B per 5 mL dilution buffer, as above) for 1
hour at room temperature. Lastly, sections were reacted in nickel-enhanced DAB
in the presence of hydrogen peroxide to visualize the target antigens.
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Marker/Antigen Abbreviation Class or
function

Associated
cell type

Glial fibrillary
acidic protein

GFAP

Intermediate
filament

Doublecortin

DCX

Microtubuleassociated
protein

Astrocytes;
neural stem
cells in SVZ
and DG
Immature
neurons in
SVZ and DG

Ionized binding
adapter
molecule 1

Iba1 (aka
AIF1)

5-bromo-2’deoxyuridine

BrdU

EF-hand
containing
calcium
binding
protein
Thymidine
analog

Neuronal nuclei

NeuN (aka
Fox3)

4’,6-diamidino2-phenylindole

DAPI

RNA splicing
factor

Antibody
source; host;
concentration
DAKO Z0334;
Rabbit;
1:1000 (IF)
CellSignaling;
Rabbit; 1:500
(IF)

Microglia,
Wako 019macrophages 19741;
Rabbit,
1:5000 (IHC)
Incorporate
into cell
during DNA
synthesis, a
marker of
proliferation
Mature
neurons

Thermo MA3071;IgG2a;
1:500(IF);
1:4000 (IHC)

Millipore
MAB377 (Ms
IgG1); ABN78
(rabbit);
1:1000 (IF)
IF

DNA minor
DNA
groove
binder
Table 5: Summary of cell-type markers and antibodies used in this dissertation. IF:
immunofluorescence; IHC: Immunohistochemistry (with avidin-peroxidase
complex and DAB detection).
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Unbiased stereology
Unbiased stereology is a method of estimating properties (number, length,
Unbiased
stereology
volume, etc.) of three-dimensional
structures
from tissue sections without making

assumptions about the size, shape, or orientation of the objects of interest
Unbiased stereology is a method of estimating properties (number, length, volume,

(Peterson 1999). Various stereology “probes” can be applied to tissue sections to
etc.) of three-dimensional structures from tissue sections without making assumptions

estimate
quantities
(Table of
6).the
One
of these
probes,
the
optical1999;
fractionator,
about thethese
size, shape,
or orientation
objects
of interest
(D. A.
Peterson,
West,
2013). Various
stereologythe
“probes”
can be
to tissue
sections to cells)
estimate
these a region
is designed
to quantify
number
of applied
features
(for example,
within
quantities. One of these probes, the optical fractionator, is designed to quantify the

of interest. The software-based optical fractionator probe superimposes a grid
number of features (for example, cells) within a region of interest. The software-based

with counting boxes at systematically-spaced intervals, and features within the
optical fractionator probe superimposes a grid with counting boxes at systematically-spaced

box are counted with specific counting rules after excluding “guard zones” at the
intervals, and features within the box are counted with specific counting rules after

tissue
surfaces
7).the
Antissue
estimate
of An
theestimate
total number
of features
excluding
“guard(Figure
zones” at
surfaces.
of the total
number ofwithin
featuresthe
within
the brainof
structure
of interest
is calculated
brain
structure
interest
is calculated
by: by:

is an estimate
the total
number
ofisfeatures,
ΣQthe sum
whereWhere
‘N’ is an‘N’
estimate
of the totalof
number
of features,
ΣQthe the sum
of is
thethe
counted
ssf is thefeatures,
section sampling
fraction
(for example,
1/6fraction
if 1 of every
sections is 1/6 if 1
offeatures,
the counted
ssf is the
section
sampling
(for6example,
asf is the area sampling fraction (the proportion of the initially defined area that
ofexamined),
every 6 sections
is examined), asf is the area sampling fraction (the proportion
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of the initially defined area that is sampled), and tsf is the thickness sampling
fraction (the fraction of the tissue section thickness that is sampled).
Use of the optical fractionator is warranted in studying cellular proliferation
in the subventricular zone, as the number of proliferating cells is high and
generally evenly distributed, especially in the dorsolateral SVZ. However, the
optical fractionator is less useful for studies of neural precursor proliferation in
the dentate gyrus, where proliferating cells are often found in discrete clusters
with large spaces in between (Noori & Fornal 2011). For this reason, and because
of the lower level of cellular proliferation in the DG versus the SVZ, absolute
counting has been advised (Noori & Fornal 2011).
Type of Measurement

Probe Used

Cell Size

Nucleator

Cell Shape

Isotrophic Fakir

Cell Number

Optical Fractionator

Table 6: Different types of probes commonly used in unbiased stereology.
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A.

B.

Anterior

C.

1 234

D.

Posterior

Figure 7: Stereology method for counting cells in the SVZ. A. Schematic of a
theoretical structure demonstrating random unbiased sampling. The sampled
volumes are the four solid cubes within the structure. The lower figure
demonstrate the 2-D cross section of the above theoretical structure with
example cell number represented by the purple colored dots. The total number of
cells in the theoretical structure is a function of mean cell density and volume of
the structure (described by the stereology equation). B. Our approach to
quantifying SVZ cells by stereology. Sections were collected from anterior to
posterior SVZ and the outline tracings of the representative SVZ are shown
bellow. C. High magnification view of the SVZ with DAB staining for BrdU. The
colored box is called the optical dissector window. D. Schematic representation of
the optical dissector window illustrating the stereology counting rules. All cell
counting was performed on MBF Bioscience Leica DM400B with Stereo
Investigator version 9.0.
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Lesion analysis
Brains were coronally cryosectioned at 40 μm and alternating sections were
mounted on gelatin-coated slides and stained for Nissl substance (excluding
olfactory bulbs and cerebellum). The TBI lesion volume was quantified from
1.4mm to 2.5mm relative to bregma using the method outlined in (Kawamata et
al 1997), (the total area of the uninjured contralateral hemisphere-total area of
the injured (ipsilesional) hemisphere, divided by the intact hemisphere). The
lesion size was thus expressed as a percentage of the unlesioned contralateral
hemisphere. Nissl stained slides were then scanned at high resolution using a
flatbed scanner and imported into Adobe Photoshop CS5, where the number of
pixels in the intact and lesioned hemispheres were measured.
Statistics
All data analysis was performed using either Minitab version 17 (Minitab,
Inc. State College, Pennsylvania, USA) or Graphpad Prism version 5.0 (GraphPad
Software, San Diego California, USA). Daily animal weights were fitted using a
nonlinear, third order polynomial (cubic) regression. Lesion volume comparisons
were done using Student’s t-test with α=0.05 as the cutoff for statistical
significance. BrdU stereological counting results was analyzed by using general
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linear model two-way ANOVA to detect interactions between alcohol treatment
and TBI injury; to compare if means of treatment groups were significantly
different, WITH-IN group analysis was performed using regression analysis with
α=0.05 as the cutoff for statistical significance. For 7 days post TBI groups, cell
count data was transformed on the natural log scale to stabilize variance and
achieve normality. For 6 weeks post TBI groups, the cell count data was
transformed using the optimal (Box-Cox) transformation to stabilize variance and
achieve normality.

CHAPTER FOUR
RESULTS
AIM 1: THE SHORT-TERM EFFECTS OF BINGE ALCOHOL AND TRAUMATIC
BRAIN INJURY ON STEM CELL RESPONSES
Gavage results in intoxicating BAL and decreased animal weight
Blood Alcohol Level (BAL)
Rat blood alcohol levels were determined by taking 500ul of blood via tail
veinipuncture one hour after the last dose of 3g/kg; this was the same time that
the animals received an experimental TBI by the CCI method. The mean BAL level
of this cohort of animals was 156.1mg/dL with a standard error of 8.3mg/dL
(figure 8A).
Rat Weights
Rats in the TBI groups were weighed during a 14 day period during which
they underwent acclimatization, binge alcohol administration, and experimental
TBI (Figure 8B). During the acclimatization period (day 1 to day 4), there were no
significant differences between treatment groups (p>0.05). During the three days
of binge alcohol administration (day 5 to day 7), there were also no significant
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differences between treatment groups (p>0.05). During the recovery period after
TBI (day 8 to day 14), the weights of the alcohol binge group were significantly
lower compared to the vehicle administration group at two time points, day
11(means 306 grams versus 318 grams respectively) and day 13 (310 grams
versus 319 grams respectively), (p<0.05).
Lesion Analysis
The lesion was confined to the right unilateral cortical region of the
sensorimotor cortex, with the center of the lesion approximately at 1.5mm
anterior, 2.5mm lateral from bregma. Lesion size was quantified for both vehicle
and binge alcohol groups at 24 hours after TBI and 7 days after TBI. At 24 hours
post TBI, lesion size was not significantly different between vehicle TBI and
alcohol TBI groups (mean lesion size was 7.2% and 5.5% respectively) (Figure 9A).
At 7 days post TBI, lesion size was also not significantly different between vehicle
TBI and alcohol TBI groups (mean lesion size was 6.4% and 9.4% respectively)
(Figure 9B).
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Acute Repeated Binge Alcohol Causes Intoxicating BAL and Transient
Weight Loss After TBI

A.

B.

* *

Figure 8 A. Alcohol administration by gastric gavage produces a mean BAL of
156.1mg/dL,+/- 8.3 SEM (n=13) B. Weight of animals before, during and after
alcohol administration and experimental TBI by controlled cortical impact (CCI).
The average weight of the alcohol group was significantly less compared to the
vehicle group on day 11 (306 vs. 318 respectively) and day 13 (310 vs. 319
respectively) (student t test, n=6, error bars=SEM).
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Acute Repeated Binge Alcohol Had No Effect on Lesion Size

A.

B.

Figure 9: Alcohol had no effect on lesion size at early time points. Lesion size is
expressed as the percentage of intact contralesional brain hemisphere. A. At 24
hours after TBI, the mean lesion size was 7.2+/- 1.4%, n=6 and 5.5+/-1.5, n=7 for
Vehicle and Alcohol groups respectively. B. At 7 days after TBI, the mean lesion
size was 6.4+/-1.5,n=5 and 9.4+/-1.1,n=10 for Vehicle and Alcohol groups
respectively. Statistical analysis was performed by Student’s t-test with p ≤0.05 as
significance criteria, error bars=SEM.
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Binge Alcohol Affects Proliferation within the SVZ at 24 hours Post TBI
TBI

Sham

B.

CC

SVZ

CC

LV

ST

LV

ST

SVZ

Vehicle

A.

CC

C.

D.

CC

SVZ

C’
ST

SVZ

ST

Alcohol

LV
LV

Figure 10: At 24 hours after injury, binge alcohol significantly increased SVZ
proliferation in sham groups (A,C) and decreased proliferation in TBI groups (B,D).
The ipsilesional SVZ is shown. LV=lateral ventricle, CC=corpus callosum, ST=
striatum, SVZ=subventricular zone. C’ is magnified view of the red boxed area in
C. Yellow arrows point to BrdU+ nuclei of SVZ cells. Scale bar=50μm.
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Binge Alcohol Affects Proliferation within the SVZ at 24 hours Post TBI

*
*

*

*

**

**

Figure 11: A. At 24 hours after injury, binge alcohol significantly increased SVZ
proliferation in sham groups and decreased proliferation in TBI groups bilaterally.
Statistical analysis was performed by two-way ANOVA, post-hoc within-group
analysis performed, * denotes p≤0.05, ** denotes p≤0.01, error bars=SEM.
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SVZ Proliferation Cell Counting by Stereology
24 hours: The ipsilesional (injured side) and contralesional (uninjured side)
were examined separately due to the unique proximity of these two SVZ
environments to the lesion (Figure 10). First, we looked at the number of BrdU+
cells in the SVZ of the ipsilesional side to detect if there was main effect of Injury
(TBI, Sham), Treatment (alcohol, vehicle) or if there was interaction between
them (Figure 11). We found that there was statistically significant effect of Injury x
Treatment interaction (table 7) (p= 0.005). Next we performed within group
analysis to determine if the means of certain groups were statistically different.
First, the mean of Vehicle TBI was significantly higher than that of Vehicle Sham
(table 8, p=0.03); TBI induced approximately a 4 fold increase in cell proliferation.
Next, when comparing Alcohol TBI against Vehicle TBI group, there was a
significant effect of alcohol reducing proliferation by approximately 2 fold (table
8, p=0.039). Interestingly, when comparing Vehicle Sham against Alcohol sham
groups, there was a significant effect of alcohol increasing proliferation by 3 fold
(table 8, p=0.038).
Then, we looked at the number of BrdU+ cells in the SVZ of the
contralesional side to detect whether there was a main effect of Injury (TBI,

94

Sham), Treatment (alcohol, vehicle) or if there was an interaction between them
(Figure 11). Similar to the ipsilesional SVZ, there was a statistically significant
effect of Injury x Treatment interaction (table 7) (p = 0.001). Next we performed
within group analysis to determine if the means of certain groups were
statistically different. Again, the mean of Vehicle TBI was significantly higher than
that of Vehicle Sham (table 8, p=0.006); TBI induced approximately a 4 fold
increase in the number of proliferating cells. Next, when comparing Alcohol TBI
against Vehicle TBI group, there was a significant effect of alcohol reducing
proliferation by almost 3 fold (table 8, p=0.016). Again, when comparing Vehicle
Sham against Alcohol sham groups, there was a significant effect of alcohol
increasing proliferation by almost 4 fold (table 8, p=0.012).
Effect
Treatment
Injury
Treatment*Injury
Ipsilesional BrdU+
F(1,23) = 0.00, F(1,23) = 1.90, F(1,23) = 10.14, p
SVZ cell number
p =0.996
p =0.183
=0.005
Contralesional
F(1,23) = 0.01, F(1,23) = 0.28, F(1,23) = 13.77, p
BrdU+ SVZ cell
p =0.931
p =0.601
=0.001
number
Table 7. BrdU+ Cell Number in The SVZ at 24 hours two-way ANOVA Results
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Effect

Within TBI

Within Sham Within
Within
Vehicle
Alcohol
Ipsilesional
F(1,23) =
F(1,23) =
F(1,23) =
F(1,23) =
+
BrdU cell #
4.85, p
4.88, p
10.94, p
1.71, p
=0.039
=0.038
=0.003
=0.205
Contralesional F(1,23) =
F(1,23) =
F(1,23) =
F(1,23) =
+
BrdU cell #
6.79, p
7.47, p
9.44, p
5.30, p
=0.016
=0.012
=0.006
=0.032
+
Table 8. BrdU Cell Number in The SVZ at 24 hours two-way ANOVA within
Analysis
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Binge Alcohol Affects Proliferation within the SVZ at 7 Days Post TBI

*
*

*
Figure 12: At 7 days after injury, binge alcohol significantly decreased
proliferation in the TBI group bilaterally. Statistical analysis was performed by
two-way ANOVA, post-hoc within-group analysis performed,* denotes p≤0.05,
error bars=SEM.
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7 Days: The ipsilesional (injured side) and contralesional (uninjured side) were
analyzed separately (Figure 12). For the Ipsilesional SVZ, there was no statistically
significant main effect of either Injury (TBI, Sham) or Treatment (Alcohol, Vehicle).
Also, there was no significant Injury x Treatment interaction (table 9) (p= 0.052).
Within group analysis showed that when comparing Alcohol TBI against the
Vehicle TBI group, a significant effect in alcohol reducing proliferation by
approximately 1.6 fold was seen (table 10, p=0.024).
Then, we looked at the number of BrdU+ cells in the SVZ of the
contralesional side. Similar to the ipsilesional SVZ, we found that there was no
statistically significant main effect of either Injury (TBI, Sham) or Treatment
(Alcohol, Vehicle). Also, there was no significant Injury x Treatment interaction
(table 9). Within group analysis showed that Alcohol TBI and Vehicle TBI groups
were significantly different; alcohol reduced proliferation by approximately 2 fold
(table 10, p=0.028).
Effect
Treatment
Injury
Treatment*Injury
Ipsilesional BrdU+
F(1,25) = 1.36, F(1,25) = 0.03, F(1,25) = 4.21, p
SVZ cell number
p =0.256
p =0.855
=0.052
Contralesional
F(1,25) = 2.58, F(1,25) = 3.37, F(1,25) = 3.07, p
BrdU+ SVZ cell
p =0.122
p =0.080
=0.094
number
Table 9. BrdU+ Cell Number in The SVZ at 7 days two-way ANOVA Results
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Effect

Within TBI

Within Sham

Within
Within
Vehicle
Alcohol
Ipsilesional
F(1,25) =
F(1,25) =
F(1,25) =
F(1,25) =
BrdU+ SVZ
5.85, p
0.38, p
2.67, p
1.89, p
cell number
=0.024
=0.543
=0.116
=0.182
Contralesional F(1,25) =
F(1,25) =
F(1,25) =
F(1,25) =
BrdU+ SVZ
5.54, p
0.01, p
0.00, p
6.46, p
cell number
=0.028
=0.926
=0.978
=0.018
Table 10. BrdU+ Cell Number in The SVZ at 7 days two-way ANOVA within
Analysis

In summary, the results from Aim #1 are:
1) Binge alcohol had no effect on lesion size.
2) Binge alcohol alone significantly increased proliferation bilaterally in the
SVZ at 24 hours only.
3) TBI alone significantly increased proliferation bilaterally in the SVZ at 24
hours after injury.
4) However, when binge alcohol was combined with TBI, binge alcohol
significantly decreased proliferation bilaterally in the SVZ of TBI injured
animals at 24 hours and 7 days after injury.
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AIM 2: THE LONG-TERM EFFECTS OF BINGE ALCOHOL AND TRAUMATIC
BRAIN INJURY ON STEM CELL RESPONSES
Lesion Analysis
As in Aim 1, the lesion was confined to the right unilateral cortical region of the
sensorimotor cortex, with the center of the lesion approximately at 1.5mm
anterior, 2.5mm lateral from bregma (Figure 13A,B). Lesion size was quantified for
both vehicle and binge alcohol groups at 6 weeks after TBI. Lesion size was not
significantly different between vehicle TBI and alcohol TBI groups (mean lesion
size was 9.7% and 8.3% respectively).
SVZ Proliferation Cell Counting by Stereology
6 weeks Total BrdU+ Cell in SVZ: We examined the ipsilesional (injured side) and
contralesional (uninjured side) separately due to the unique proximity of these
two SVZ environments to the lesion (Figure 14). First, we looked at the number of
BrdU+ cells in the SVZ of the ipsilesional side to detect if there was a main effect of
Injury (TBI, Sham), Treatment (alcohol, vehicle) or if there was interaction
between them (Figure 15). We found that there was a statistically significant main
effect of Injury (TBI, Sham) (p=0.000), but no statistically significant effects of
Treatment or Injury x Treatment interaction (table 11). Next we performed within
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group analysis to determine if the means of certain groups were statistically
different. First, we saw that the mean of Vehicle TBI was significantly higher than
that of Vehicle Sham (table 12, p=0.000); TBI induced more than a 4 fold increase
in the number of proliferated cell in the SVZ. The mean SVZ BrdU+ cell number of
Alcohol TBI group was significantly higher than Alcohol Sham group (more than a
4 fold increase) (table 12, p=0.000).
In contrast to the ipsilesional SVZ, no statistically significant effects of Injury,
Treatment or Injury x Treatment interaction in the contralesional SVZ was found
(table 11).
Effect
Ipsilesional BrdU+
SVZ cell number

Injury
Treatment*Injury
F(1,25) =
F(1,25) = 0.02, p
137.54, p
=0.904
=0.000
+
Contralesional BrdU F(1,25) = 0.38, F(1,25) = 0.34, F(1,25) = 0.03, p
SVZ cell number
p =0.542
p =0.566
=0.854
+
Table 11. BrdU Cell Number in The SVZ at 6 weeks two-way ANOVA Results
Effect

Treatment
F(1,25) = 1.40,
p =0.249

Within TBI

Within Sham

Within
Vehicle
F(1,25) =
67.34, p
=0.000
N/A

Within
Alcohol
F(1,25) =
70.22, p
=0.000
N/A

Ipsilesional
F(1,25) =
F(1,25) =
+
BrdU SVZ cell 0.61, p
0.79, p
number
=0.443
=0.383
Contralesional N/A
N/A
+
BrdU SVZ cell
number
Table 12. BrdU+ Cell Number in The SVZ at 6 weeks two-way ANOVA within
Analysis
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Repeated Binge Alcohol Had No Effect on Long-term Lesion Size

A.

B.

C.
C

Figure 13: Alcohol had no effect on lesion size at the 6 weeks time point. A. Gross
rat brain with a TBI in the right sensorimotor cortex at 6 weeks post TBI. B.
Coronal brain sections of a rat with TBI stained for Nissl. Red arrows point to the
location of the TBI lesion. C. At 6 weeks after TBI, the mean lesion size was 9.7+/1.8%, n=9 and 8.3+/-1.7, n=9 for Vehicle and Alcohol groups respectively.
Statistical analysis was performed by Student’s t-test with p ≥0.05 as significance
criteria.
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At 6 Weeks Post-TBI, TBI Increased Proliferation within the Ipsilesional
SVZ; Binge Alcohol Had No Effect on SVZ Proliferation
Sham

TBI

B.
ST

SVZ
LV

LV

ST

Vehicle

SVZ

A.

Green=BrdU

C.

Figure 14: BrdU immunofluorescence showing at 6 weeks after injury, TBI
significantly increased proliferation in the ipsilateral SVZ. A-D. Enlargements of
the dorsolateral SVZs on the ipsilesional side of the brain. Binge alcohol had no
effect on SVZ proliferation after TBI. LV= lateral ventricle, ST= striatum, SVZ=
subventricular zone. Yellow arrows point to BrdU+ nuclei of SVZ cells. Scale bar =
50μm.

ST

ST

LV

SVZ

Alcohol

LV

SVZ

D.
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At 6 Weeks Post-TBI, TBI Increased Proliferation within the Ipsilesional
SVZ; Binge Alcohol Had No Effect on SVZ Proliferation

***
***

ns

Figure 15: Statistical analysis was performed by two-way ANOVA, post-hoc
within-group analysis performed, *** denotes p≤0.001, error bars=SEM.
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6 weeks (BrdU+/ DCX+) Double-labeled Cell in SVZ (Figure 16, 17): For the
ipsilesional SVZ, there was a statistically significant main effect of Injury (TBI,
Sham) but not Treatment (Alcohol, Vehicle); additionally, there was a significant
Injury x Treatment interaction (table 13, p= 0.029). Within group analysis showed
that when comparing Vehicle Sham against Vehicle TBI, there was a significant
effect in TBI increasing the number of double-labeled (BrdU+ /DCX+) cells by more
than 11 fold (table 14, p=0.000). When comparing Alcohol Sham against Alcohol
TBI, a significant effect in TBI increasing the number of double-labeled cells by
about 7 fold was detected (table 14, p=0.000). When comparing Vehicle TBI
against Alcohol TBI, there was a significant effect of alcohol decreasing the
number of double-labeled cells by about 38% (table 14, p=0.006).
Then, the number of double-labeled (BrdU+/ DCX+) cells in the SVZ of the
contralesional side was examined (Figure 17). There was a statistically significant
main effect of Injury (table 13, p=0.000) but not Treatment. Furthermore, there
was a significant Injury x Treatment interaction (table 13, p=0.021). Within group
analysis showed that Vehicle TBI and Vehicle Sham groups were significantly
different; TBI increased the number of double-labeled (BrdU+/ DCX+) cells by more
than 7 fold (table 14, p=0.000). Alcohol Sham and Vehicle Sham groups were also
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significantly different, with alcohol increasing the number of double-labeled
(BrdU+/ DCX+) cells by more than 2 fold (table 14, p=0.019).
Effect
Ipsilesional double
labeled cell number

Treatment
F(1,25) = 3.18,
p =0.088

Injury
F(1,25) =
117.12, p
=0.000
F(1,25) =
18.50, p =0.000

Treatment*Injury
F(1,25) = 5.43, p
=0.029

Contralesional
F(1,25) = 1.50,
F(1,25) = 6.16, p
double labeled cell
p =0.234
=0.021
number
Table 13. (BrdU+/ DCX+) Double Labeled Cell Number in The SVZ at 6 weeks twoway ANOVA Results

Effect

Within TBI

Within Sham

Within
Vehicle
F(1,25) =
86.49, p
=0.000

Within
Alcohol
F(1,25) =
36.06, p
=0.000

Ipsilesional
F(1,25) =
F(1,25) =
double
9.17, p
0.14, p
labeled cell
=0.006
=0.713
number
Contralesional F(1,25) =
F(1,25) =
F(1,25) =
F(1,25) =
double
0.86, p
6.38, p
23.00, p
1.65, p
labeled cell
=0.365
=0.019
=0.000
=0.212
number
Table 14. (BrdU+ & DCX+) Double Labeled Cell Number in The SVZ at 6 weeks
two-way ANOVA within Analysis
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Alcohol TBI

Vehicle TBI

Repeated Binge Alcohol Decreased Neuronal Differentiation within the
SVZ at 6 Weeks Post-TBI

Green=BrdU

Red=DCX

Figure 16: At 6 weeks after injury, binge alcohol significantly decreased neuronal
differentiation in the ipsilesional SVZ. Several sections were chosen for
immunofluorescence to demonstrate labeling. First column imaged at 400x
magnification, scale bar = 75 μm. Second column imaged at 1000x, scale
bar=10μm.
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Repeated Binge Alcohol Decreased Neuronal Differentiation within the
SVZ at 6 Weeks Post-TBI

***

*
***

**

***

Figure 17: At 6 weeks after injury, binge alcohol significantly decreased neuronal
differentiation. Statistical analysis was performed by two-way ANOVA, post-hoc
within-group analysis performed,* denotes p≤0.05, ** p≤0.01,and *** p≤0.001,
error bars=SEM.
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6 weeks (BrdU+/ DCX-) Single-labeled Cell in SVZ (Figure 19): For the ipsilesional
SVZ, we found that there was a statistically significant main effect of Injury (TBI,
Sham), (table 15, p=0.000), but not Treatment (Alcohol, Vehicle); we did not
detect a significant Injury x Treatment interaction. Within group analysis showed
that when comparing Vehicle Sham against Vehicle TBI, there was a significant
effect of TBI increasing the number of single-labeled (BrdU+/ DCX-) cells by more
than 3 fold (table 16, p=0.000). When comparing Alcohol Sham against Alcohol
TBI, there was a significant effect of TBI increasing the number of single-labeled
cells by about 4 fold (table 16, p=0.000).
On the contralesional side, we did not detect any statistically significant main
effect of Injury or Treatment (Figure 19). Furthermore, there was no significant
Injury x Treatment interaction.
Effect
Treatment
Injury
Treatment*Injury
Ipsilesional single
F(1,25) = 0.71, F(1,25) =
F(1,25) = 0.11, p
labeled cell number p =0.408
83.19, p =0.000 =0.740
Contralesional single F(1,25) = 0.16, F(1,25) = 0.06, F(1,25) = 0.09, p
labeled cell number p =0.692
p =0.811
=0.765
+
Table 15. (BrdU & DCX ) Single Labeled Cell Number in The SVZ at 6 weeks twoway ANOVA Results
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Effect

Within TBI

Within Sham

Within
Vehicle
F(1,25) =
38.59, p
=0.000
N/A

Within
Alcohol
F(1,25)
=44.72, p
=0.000
N/A

Ipsilesional
F(1,25) =
F(1,25) =
single labeled 0.14, p
0.65, p
cell number
=0.712
=0.430
Contralesional N/A
N/A
single labeled
cell number
Table 16. (BrdU+ & DCX-) Single Labeled Cell Number in The SVZ at 6 weeks twoway ANOVA within Analysis
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Repeated Binge Alcohol Does Not Affect Non-Neuronal Differentiation
within the SVZ at 6 Weeks Post-TBI
TBI

E.

ST

LV

Green=BrdU

SVZ

B.

SVZ

ST

Vehicle

A.

Sham

LV

Red=GFAP

D.

F.

LV

LV

ST

SVZ

ST

Alcohol

SVZ

C.

Figure 18. Immunofluorescence of BrdU and the astrocyte marker GFAP. A-D.
Enlargements of the dorsolateral SVZs of the ipsilesional side of the brain. There
appears to be little co-localization of BrdU signal and GFAP signal in the sham
groups. In TBI groups, more BrdU co-localize with GFAP signal; however, there
was no noticeable difference between vehicle and alcohol groups. LV= lateral
ventricle, ST= striatum, SVZ= subventricular zone. Scale bar=150μm.
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Repeated Binge Alcohol Did Not Affect Non-Neuronal Differentiation
within the SVZ at 6 Weeks Post-TBI

***
***

ns

Figure 19: Repeated binge alcohol did not affect glial proliferation as measured at
6 weeks after injury. Statistical analysis was performed by two-way ANOVA, posthoc within-group analysis was performed,*** denotes p≤0.001, error bars=SEM.
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Vehicle TBI

Vehicle TBI

Repeated Binge Alcohol Does Not Appear to Affect the Number of
Neurons with Mature Phenotypes Within the SVZ and Perilesional Area
at 6 Weeks Post-TBI

Red=NeuN

Alcohol TBI

Alcohol TBI

Green=BrdU

Figure 20: Immunofluorescence of BrdU and the mature neuronal marker NeuN.
Images in the left column are from the perilesional cortical area (blue box).
Images in the right column are from the dorsolateral SVZ area (red box). There
appeared to be little co-localization of BrdU and NeuN signal in either the SVZ or
the cortical area. No noticeable differences between vehicle and alcohol groups
were observed. Scale bar=10μm.
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6 weeks (BrdU+/ DCX+) Double-labeled Cells in the Perilesional Area (figure 21):
There was no statistically significant difference between Vehicle TBI and Alcohol
TBI groups.
6 weeks (BrdU+/ DCX+) Double-labeled Cell in RMS (figures 22 and 23): We found
that there was a statistically significant main effect of Injury (TBI, Sham), (table 17,
p=0.000), but not Treatment (Alcohol, Vehicle); we did not detect a significant
Injury x Treatment interaction. Within group analysis showed that when
comparing Vehicle Sham against Vehicle TBI, there was a significant effect of TBI
increasing the number of double-labeled (BrdU+/ DCX+) cells by about 2 fold (table
18, p=0.001). When comparing Alcohol Sham against Alcohol TBI, we also saw a
significant effect of TBI increasing the number of double-labeled cells (table 18,
p=0.037).
Effect
Treatment
Injury
Treatment*Injury
RMS double labeled F(1,26) = 1.12, F(1,26) =
F(1,26) = 1.87, p
cell number
p =0.302
19.48, p =0.000 =0.185
Table 17. Neuronal Migration in the RMS at 6 weeks two-way ANOVA Results
Effect

Within TBI

Within Sham

Within
Within
Vehicle
Alcohol
RMS double F(1,26) =
F(1,26) =
F(1,26) =
F(1,26) =
labeled cell
3.62, p
0.04, p
15.85, p
4.91, p
number
=0.070
=0.843
=0.001
=0.037
Table 18. Neuronal Migration in The RMS at 6 weeks two-way ANOVA within
Analysis
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Repeated Binge Alcohol Did not Affect Peri-lesional Migration of
Immature Neurons

TBI lesion

Figure 21: At 6 weeks after injury, binge alcohol did not affect the migration of
neuroblasts toward the peri-lesional area. Statistical analysis was performed by
Student’s t-test with significant criteria of p≤0.05, error bars=SEM. OB: Olfactory
bulb, RMS: Rostral migratory stream, Str: striatum, SVZ: subventricular zone, LV:
lateral ventricle, HPC: hippocampus, DG: dentate gyrus, SGZ: subgranular zone,
4V: 4th ventricle, CCSC: central canal of the spinal cord, CTX: cortex. Diagram
adapted from (Emsley et al 2005).
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TBI increased RMS Migration
TBI

Sham

Vehicle

TBI lesion

C.

E.

D.

F.

Alcohol

A.

B.

Figure 22: At 6 weeks after injury, TBI significantly increased migration of SVZ
derived neuroblasts toward the olfactory bulb. A. Diagram of the rostral migratory
stream (RMS) the pathway that neuroblasts take toward the olfactory bulbs,
shown in green. B. Coronal section of rat brain immunolabeled for Doublecortin
(DCX) and BrdU. Area in the blue box is the olfactory bulb nucleus (OBN), which is
a part of the RMS. C-F. Enlargements of the ipsilateral OBN, with BrdU+ cells as
black and DCX+ cells as dark red. Diagram in A was adapted from (Emsley et al
2005). Scale bar=50μm.
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TBI increased RMS Migration and Binge Alcohol Did Not Affect This
Process
TBI lesion

***
***

Figure 23: At 6 weeks after injury, binge alcohol did not affect migration of SVZ
derived neuroblasts toward the olfactory bulb. Statistical analysis was performed
by two-way ANOVA, post-hoc within-group analysis performed, *** denotes
p≤0.001, error bars=SEM. OB: Olfactory bulb, RMS: Rostral migratory stream, Str:
striatum, SVZ: subventricular zone, LV: lateral ventricle, HPC: hippocampus, DG:
dentate gyrus, SGZ: subgranular zone, 4V: 4th ventricle, CCSC: central canal of the
spinal cord, CTX: cortex. Diagram adapted from (Emsley et al 2005).
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In Summary, the results from Aim #2 are:
1) Binge alcohol had no effect on lesion size as measured at 6 weeks after TBI.
2) Binge alcohol decreased neuronal differentiation of SVZ derived cells at 6
weeks after TBI.
3) TBI alone increased RMS migration to the olfactory bulb.
4) Binge alcohol did not affect migration of immature neurons to the
perilesional area or to the olfactory bulb.

CHAPTER FIVE
DISCUSSION
TBI is a significant health crisis as many survivors of TBI face disabilities and
a difficult path to recovery. Alcohol consumption and intoxication is a lifestyle
factor that strongly contributes to suffering a TBI. In fact, a large fraction of TBI
patients are positive for blood alcohol levels higher than the 0.08 legal limit at the
time of injury (Parry-Jones et al 2006). Binge drinking is the most common way in
which alcohol is consumed and it has been shown to be extremely widespread in
the adolescence and adult populations in our society (CDC Vitalsigns, 2012).
Despite the strong association of alcohol consumption to TBI injuries, the
biological effect of alcohol consumption and intoxication on the TBI recovery
process is not well understood. An earlier behavioral study using a rat model for
binge alcohol consumption and TBI indicated that a three day binge alcohol
administration prior to cortical injury by CCI significantly decreased fine motor
skill recovery when measured 8 weeks after TBI (Vaagenes et al 2015). However,
the mechanism behind this alcohol-induced impairment is not known. Therefore,
in this dissertation, we used the same binge alcohol and TBI model previously
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developed in our lab to explore the combined effect of binge alcohol and TBI on
the neural stem cell response.
Our results showed that alcohol given for three consecutive days (a binge
pattern of alcohol consumption) before a moderate TBI to the right forelimb
motor cortex leads to a significant reduction in short term SVZ proliferation as
measured at 24 hours and 7 days post injury. Binge alcohol did not affect the
retention of proliferated cell in the SVZ as measured at 6 weeks post injury.
However, binge alcohol significantly reduced the number of proliferated cells that
differentiated into neurons in the SVZ. Binge alcohol did not have significant
effects on lesion size, or migration of new neurons to the perilesional area and
the olfactory bulb. Additionally, we confirmed earlier literature that our model of
TBI using the controlled cortical impact method produced a significant increase in
the number of proliferating cells bilaterally in the SVZ when measured at 24 hours
and 7 days post injury and ipsilateral at the 6 week time point. TBI also induced a
significant increase in migration of new neurons toward the perilesional area and
the olfactory bulb via the RMS pathway. An interesting effect of binge alcohol
alone was its effect on increasing SVZ proliferation when measured 24 hours after
the last binge episode. Overall, we found that binge alcohol potently affected
neurogenesis after TBI, and this might be the reason behind the reduced
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functional recovery as observed in the same animal model as we reported
previously (Vaagenes et al 2015).
Alcohol had been found by various groups to have detrimental effects on
the lesion size of animals (Kelly et al 1997). Additionally, there is evidence to
suggest that alcohol affects aquaporin expression, which could lead to elevated
edema in animals intoxicated with alcohol, thus leading to an increase in lesion
size (Sripathirathan et al 2009). However, we found that lesion size was not
affected in our rat model of binge alcohol and TBI at the acute time point of 24
hours, sub-acute time point of 7 days or the chronic time point of 6 weeks. This
suggests that alcohol intoxication at the level experienced in our model does not
affect the edema process after TBI. Furthermore, our results suggest that binge
alcohol consumption did not have detrimental effects on perilesional cell death
(apoptotic or necrotic) or lesion site degeneration. However, to further
investigate this process, we would need to perform staining using specific markers
for apoptosis, necrosis or degeneration.
Additionally, we also confirmed observations from past studies regarding
the general increase in SVZ proliferation post-TBI. However, we observed some
differences regarding the time-course of this proliferative response. One recent
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study noted that there were significant variations in the SVZ proliferative
response following a TBI (Chang et al 2016). For instance, species differences (rats
versus mice) and different TBI methods (CCI versus MFP versus weight drop…etc)
can account for the variation in the SVZ proliferative response as observed in
these studies (Tzeng & Wu 1999), (Szele & Chesselet 1996),(Goings et al 2002).
However, the consensus is that in rats, during the first five days after injury, SVZ
proliferation is unchanged. However, we saw that TBI alone induced up to a 4 fold
increase in SVZ proliferation at the 24 hour time point (Figure 10 and 11). The
difference in this result might be due to the difference in the TBI model used, for
instance, (Tzeng & Wu 1999) used the stab wound model to inflict TBI while
(Goodus et al 2014) used a pediatric rat TBI model. While another group used a
thermal coagulation model to produce a cortical lesion that was distal to the SVZ
to show that within the first 5 days after injury, there was no change in
proliferation (Gotts & Chesselet 2005). The model used in this dissertation, i.e.,
CCI, is thought by others to be a more appropriate model for closed-head TBI with
contusion (Dixon et al 1991), produces a focal TBI lesion that is proximal to the
SVZ, and thus might explain the marked and almost immediate elevation in SVZ
proliferation.
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Furthermore, according to two groups which used aspiration lesion and
diffuse TBI models, SVZ proliferation reached a maximum of around 2 fold above
baseline at 5-7 days post-TBI (Szele & Chesselet 1996), (Bye et al 2011). In our
model, at 7 days post injury there was no significant difference in SVZ
proliferation in TBI versus the sham group (Figure 12). This result indicates that
the proliferative maximum had been reached between days 1 and before day 7,
and that the rate of new cell incorporation into the SVZ equals the rate of
migration of cells away from the SVZ. Again, as in the 24 hours post-TBI result, we
feel that the difference in our TBI model is able to explain why we observed SVZ
proliferation reaching a maximum before 7 days.
At 7 days after TBI, the total number of BrdU labeled cells in the SVZ of
animals in all the groups was dramatically higher compared to the 24 hour time
point because of the accumulation of these cells during the 7 days of BrdU
injection/labeling. The distribution of proliferated cells was dramatically different
when we observed the 7 day survival animals compared to the 24 hour animals.
At 24 hours, we only observed BrdU+ cells in the SVZ and perilesional area; at 7
days, we observed BrdU+ cells in a number of other brain structures such as the
striatum and RMS. This indicated that newborn cells from the SVZ were migrating
toward other brain structures. It is possible that alcohol could increase SVZ cell
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death and that is why we observed less BrdU+ cells in the SVZ of TBI animals
exposed to alcohol compared to vehicle. This is unlikely, however, due to the
relatively low dose of alcohol that we used and thus less likely to induce
neurodegeneration/cell death. Furthermore, alcohol/sham animals in our study
had significantly more proliferation compared to vehicle/sham animals and thus
we do not believe that alcohol caused an increase in cell death.
A novel result from this study was that binge alcohol alone elicited a
proliferative response from the SVZ. Alcohol treated sham animals exhibited up to
a 4 fold increase in BrdU+ cells compared to vehicle treated sham animals. This
increase is in the same magnitude as an increase after TBI alone (Figure 10 and
11). This is in particular contrast with previous studies using different alcohol
intoxication models in rodents (either acute or chronic) indicating that alcohol
caused significant depression in SVZ and SGZ proliferation (Anderson et al 2012)
and (Nixon & Crews 2002). One report found that after discontinuing chronic
alcohol administration, there was an increase in SGZ cell number at day 2 and 7
after cessation (Anderson et al 2012). Similar studies have found similar
proliferation bursts in the SVZ (Hansson et al 2010); however, these studies used
chronic doses of alcohol for extended periods of time (up to 7 weeks). We believe
that we are the first to observe this SVZ burst of proliferation at 24 hours after the
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last dose of alcohol following three days of moderate binge. It is possible that the
three days moderate binge paradigm that we used was enough to cause
neurodegeneration in the CNS, which in turn acts as an injury to stimulate an
increase in neurogenesis. Additionally, reactive oxygen species (ROS) are elevated
in the enzymatic degradation of alcohol. There is strong evidence that moderate
ROS increase can stimulate neurogenesis (Le Belle et al 2011). Therefore, it will be
important to further characterize this unique SVZ response by employing different
markers to detect neurodegeneration, ROS and cell death in different brain
regions in future studies.
Important to the goal of this dissertation, we found that at the 24 hour
time point, in animals that received binge alcohol and TBI, there was a 3 fold
decrease in proliferating cells in the SVZ. To our knowledge, we are the first group
to show that alcohol in the context of TBI resulted in decreased overall SVZ
proliferation. This is what we predicted in our hypothesis based on our previous
observation that alcohol/TBI rats performed worse in the skilled forelimbreaching task compared to vehicle/TBI rats. It remains to be determined whether
SVZ proliferation contributed significantly to the performance on the skilled
forelimb-reaching task. Although not examined explicitly in this dissertation, this
may occur through the production of new interneurons in the olfactory bulb
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(granular cells and perigranular cells, Figure 2). New OB granular and perigranular
cells are inhibitory interneurons that have modulatory functions in the olfaction
neural circuitry that is important in a process called pattern separation (Sahay et
al 2011b).Furthermore, one important study showed that the skilled forelimb
reaching task relies heavily on olfaction (Whishaw & Tomie 1989).This group used
rats that were trained to reach food through a small opening; when these animals
had their vision blocked by the mean of eye patches, their reaching performance
was not affected. However, when the olfactory bulb was removed, they
experienced profound impairments in the reaching task. These findings point to
the possibility that reduced SVZ-OB neurogenesis due to alcohol could lead to
impaired olfaction pattern separation and in turn cause deficits in the skilled
forelimb reaching task.
Binge alcohol and TBI alone increased proliferation, but the combination of
the two factors led to decreased proliferation in the SVZ. There are several
mechanisms that might explain this observation:
Inflammatory response: TBI has an important inflammation
component in the primary injury phase. Alcohol is known to increase CNS
inflammation via its effect on microglia (Marshall et al 2013). It is possible that the
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combined magnitude of inflammation in TBI/binge alcohol animals is higher than
in TBI or binge alcohol animals alone. A certain amount of inflammation can
stimulate neurogenesis, however, if inflammation reaches a high threshold, it may
cause the SVZ microenvironment to be non-supportive for neurogenesis. For
instance, there is strong evidence for pro-inflammatory cytokines such as IL-1b
suppressing hippocampal neurogenesis (Goshen et al 2008).
Reactive oxygen species (ROS): Alcohol metabolism produces ROS
and primary events following TBI also lead to high ROS levels. Therefore, in TBI
and alcohol administered animals, ROS levels could become additive from the two
conditions. This combined elevated ROS from TBI and alcohol could be inhibitory
to proliferation. As previously noted, low concentration of ROS can stimulate
neurogenesis, likely through a mechanism involving elevated NF-kB (Ruiz-Ramos
et al 2009). However, extremely high levels of ROS could inhibit NSC proliferation
(Limoli et al 2006). Furthermore, extreme levels of ROS could lead to an increased
rate of cell death of recently proliferated cells due to an increased rate of DNA
damage (Figure 4).
BDNF availability: Growth factors are crucial to the neurogenesis
process. For instance, BDNF enhances survival and in certain cases serves as a
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chemokine to attract new neurons toward lesion areas (Rostami et al 2014). TBI
increases BDNF expression through several cellular mechanisms: astrocytes,
microglia and vascular cells all secrete BDNF. Alcohol however, decreases BDNF
expression and thus lowers the potential neurogenesis that is possible if there is
only TBI alone.
Technical Issues:
BrdU injection allows us to label and birth-date the proliferating cells;
however, there are some drawbacks of this technique that deserve some thought
when interpreting the data. For instance, while BrdU readily crosses the BBB and
becomes available to CNS cells for incorporation into their DNA, the bioavailability
of BrdU is short. It is rapidly degraded and only available to cells for about 2 hours
after injection. This likely means that we were only seeing a fraction of
proliferation that actually happened during the observed time interval. Although
we did use daily injections of BrdU for the 7 day group of animals, we would still
not be able to label all proliferating events. An alternative approach would be to
inject BrdU more frequently, multiple times per day; however, the drawback of
such an approach would be increased animal stress and exposure to anesthesia.
Additionally, there are some concerns that after TBI, there is an increase in BBB
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leakiness, which might lead to higher BrdU permeability into the brain
parenchyma. However, we did used a relatively high BrdU dose of 100mg/kg
which means the available concentration in the brain reached the saturation
point, so any further increase in BrdU permeability after TBI should not affect the
number of BrdU+ cells. Due to the short bioavailability of BrdU, in future studies, it
would be interesting to include a group of animals that would be sacrificed at the
2-3 hour post-TBI and BrdU injection. This approach would enable us to rule out
the possibility that cell death or migration of recently proliferated cells might
impact the number of BrdU+ cell in the SVZ.
An important consideration when looking at our results showing alcohol
decreased the SVZ proliferative response after TBI is how this translates to human
patients. While production of new brain cells by neurogenesis was observed in
the human brain, no conclusive evidence exists for their roles (Chang et al 2016).
Additionally, neurogenesis in the human brain happens at a much lower level
compared to the rodent brain (Curtis et al 2007), thus limiting the translatability
of rodent neurogenesis findings. Also, newly proliferated cells must become
functionally relevant in the adult brain post TBI for them to have any role in the
recovery process. These newly generated cells from the SVZ would need to
undergo the differentiation process to become either neurons or glia and they
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must also migrate to different brain regions. Therefore, we sought to explore
these aspects of neurogenesis in our second aim.
One of the most interesting aspects of neurogenesis is whether the
newborn cells become functionally relevant in the CNS. In the rodent system, the
roles of newborn SVZ and DG cells are perhaps the best studied and understood.
Yet their roles after CNS injury are less well known and this area of research is still
very active as the roles of NSC are hotly debated (Garthe & Kempermann 2013).
The goal for this part of the dissertation was to determine the NSC responses
after TBI in the chronic TBI phase. These long-term responses include the survival
of proliferated cells, their differentiation into neuronal and glial lineages and the
migration of neuronal differentiated cells to various areas of the CNS. To this end,
we performed BrdU injections for the first 7 days following TBI to label all
proliferating cells within this period of time. The animals were allowed to survive
for 6 weeks. According to previous behavioral studies in our lab, this is sufficient
time for animals to reach a functional plateau, which in human corresponds to
the chronic phase of TBI.
We quantified the total number of BrdU+ cells in the SVZ of the prolonged
survival time point; BrdU+ cells are those that had been labeled during the first 7
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days after injury. We found at the acute time point of 24 hours and sub-acute 7
days after TBI, the contralesional SVZ robustly responded to the TBI by increasing
proliferation by up to 5 fold; however, at 6 weeks after TBI, the number of BrdU+
cells retained in the contralesional SVZ decreased to baseline levels, essentially
indistinguishable from sham groups (irrespective of alcohol or vehicle treatment).
It is possible that these BrdU+ cells seen at the earlier time points had migrated
out from the SVZ to other parts of the CNS such as the striatum, corpus callosum,
the cortex or toward the olfactory bulb.
Interestingly, we found significant retention of BrdU+ cells in the ipsilesional
SVZ in TBI animals and this level of retention was virtually the same across alcohol
and vehicle treated groups. There were around 60,000 cells in the ipsilesional SVZ
of TBI animals, which is around 4 fold higher than baseline levels (sham groups).
This is not surprising considering the strong evidence in the literature suggesting
that newly proliferated cells could survive better in the SVZ after TBI. For instance,
one group found that there was a decrease of TUNEL positive cells in the SVZ of
animals after CCI (Theus et al 2010). TBI might have altered the ipsilesional SVZ
microenvironment to support more proliferating cells. By contrast, another group
reached different conclusions in their model of TBI and neurogenesis (Acosta et al
2013). This group examined the long-term effect of TBI on SVZ neurogenesis. They
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found that at 8 weeks post TBI, there was significant reduction in Ki67+ cells in the
SVZ of TBI animals. This is in stark contrast to our finding of elevated BrdU+ in TBI
animals at 6 weeks. It is possible that the use of different cell proliferation
markers could partially explain the discrepancy. Ki67 is expressed during all
phases of mitosis and is necessary for cell cycle processes (Mandyam et al 2007).
Ki67 has been shown to correlate with BrdU staining; however, Ki67 has a half-life
of 17 hours, which make it difficult to ascertain when the cell proliferation event
happens.
Binge alcohol did not affect the long-term survival of proliferated cells in
the SVZ in our model. This result is somewhat unexpected and is in contrast with
previous studies on alcohol binge. For instance, in a prominent study, alcohol was
given to rats 4 days in a row; they detected significant reduction in the survival of
new hippocampal cells 4 weeks after the binge episodes (Nixon & Crews 2002). It
is possible there are regional differences in response to binge alcohol, i.e.,
hippocampus being more sensitive to binge alcohol than the SVZ. Additionally, the
binge alcohol given to the animals in that study was a very high dose of 5g/kg for
4 days (versus our model of 3g/kg for 3 days) which could contribute to the
differences observed.
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Neuronal differentiation was measured as the number of cells that
expressed both BrdU and DCX (doublecortin). DCX is expressed by developing
neurons and is thus a reliable marker for neuronal differentiation (Francis et al
1999). We found that TBI alone significantly induced an increase in neuronal
differentiation bilaterally in the SVZ. This observation is in agreement with the
literature on neuronal differentiation after TBI. For instance, one group used
transgenic mice that had YFP tagged to new neurons to show that new neurons
were populated in the dorsal SVZ and expressed DCX; they used the same CCI
model and detected these cells at 6 week post TBI similar to our approach
(Mierzwa et al 2014). It is possible that the microenvironment of the SVZ is
changed after TBI and thus more permissive to the neuronal differentiation of
new proliferating cells; for instance, one study found BDNF expression to be
increased in the hippocampus after TBI (Hicks et al 1997).
Intriguingly, we found that binge alcohol decreased the number of early
SVZ proliferating cells differentiated into the neuronal lineage 6 weeks after TBI.
Stereological quantification of the SVZ area showed that alcohol significantly
reduced the number of BrdU+/DCX+ double-labeled cell by 38% on the ipsilesional
side (Figure 17). Immunofluorescence imaging confirmed our counting data
showing reduced co-localization of BrdU and DCX signaling in TBI animals that
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were alcohol treated versus vehicle (Figure 16). We suspect that binge alcohol
might have affected neuronal differentiation by changing expression levels of
trophic factors in the brain, for instance, BDNF, insulin, GDNF and EGF (Janak et al
2006). One group found that high dose alcohol administration lead to depressive
like behavior and reduction in hippocampal BDNF (Hauser et al 2011). One
clinical study looking at serum levels of several trophic factors found that alcohol
dependent patients had reduced GDNF and BDNF (Heberlein et al 2010).
We did not expect our binge alcohol administration paradigm to have such
long-term effect on neuronal differentiation post TBI. It is possible that alcohol is
acting on neuronal differentiation via epigenetic mechanisms. One study found
that there was reduced methylation of the CpG (Cytosin-phosphatidyl-Guanin) of
the promoter of NGF (nerve growth factor) in the serum of alcohol dependent
patients (Heberlein et al 2013). Furthermore, BDNF, a trophic factor important in
the neuronal differentiation process is found to be affected by alcohol by
epigenetic regulation in mice (Stragier et al 2015).
Another finding from this dissertation was that binge alcohol affects
neuronal differentiation. New SVZ derived cells can differentiate into the three
main cells of the CNS, i.e., neurons, astrocytes and oligodendrocytes. We
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quantified the number of cells in the SVZ at 6 weeks that were positive for BrdU
and negative for DCX. BrdU+/DCX- cells are early-proliferated cells that
differentiated into the non-neuronal lineage, either astrocytes or
oligodendrocytes. Alcohol did not change the number of BrdU+/DCX- cells in the
SVZ of TBI animals (Figure 19). It appears that the vast majority of BrdU+/DCXcells were astrocytes according to qualitative microscopic observation of GFAP
and BrdU staining (Figure 18). However, it is also possible that BrdU+/DCX- cells
might be microglia or infiltrating blood-borne macrophages. These types of
immune cells have been found to proliferate after TBI (Lalancette-Hébert et al
2007). While alcohol did not have an effect on total glial differentiation, it could
have effects on specific types of glia; for instance, there was qualitatively more
BrdU+/GFAP+ cells in our microscopic observation of the Alcohol TBI compared to
Vehicle TBI groups (Figure 18).
Migration is an important aspect of SVZ neurogenesis. For instance, in the
SVZ-OB system, new putative neurons travel through a network of astrocytes and
vascular cells to reach their destination in the OB. The molecular and cellular
interactions that these migratory cells experienced during their excursion play an
important role in their eventual differentiation into functional neurons. Alcohol
exposure had been found to profoundly affect neuronal migration. For instance,
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in a model of prenatal alcohol exposure, alcohol was found to decrease migration
of serotonin neurons (Zhou et al 2001). Furthermore, after TBI, neuronal
migration toward the perilesional area was increased; for instance, more DCX+
cells were detected in the TBI lesion area in a model of TBI (Chang et al 2016)
First, we determined whether binge alcohol differentially affected TBI
induced perilesional migration of new neurons. TBI itself induced robust
migration of new cells toward the perilesional area (defined as 100um from the
edge of the lesion). The total number of BrdU+/DCX+ cells in the perilesional area
was around 12,000 cells which is the same magnitude as the number of
BrdU+/DCX+ in the SVZ. However, the total volume of the perilesional area is much
larger than that of the SVZ so the effective density of new neurons in the
perilesional area is much less. Furthermore, qualitative microscopic observation
of sham animals showed there were little to no BrdU+/DCX+ cells in the
neocortical area dorsal to the SVZ. However, there was no evidence for binge
alcohol having any effect on perilesional area migration of new neurons in TBI
animals (Figure 21). In addition to the presence of new migratory neurons in the
perilesional area, there was a large population of proliferating cells in this area.
However, these BrdU+ cells did not express markers for mature neurons
(BrdU+/NeuN+, Figure 20). Our observation is in line with the literature on post-TBI
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migration to the cortical area in that there are rarely any new cells expressing
markers of mature cortical neurons (Chang et al 2016).
Migration from the SVZ to the cortex has important implications in the
recovery post-TBI. The presence of new neurons in the perilesional area raises the
possibility that these new cells can become functionally integrated and can take
over the role of previously dead neurons. This event however has not been well
documented. There is also the possibility that newborn neurons contribute to
functional recovery in structures other than the perilesional area. There is strong
evidence that olfactory function contributes greatly to the skilled forelimb
reaching task performance (Whishaw & Tomie 1989). We quantified the migration
of new neurons in the SVZ-OB pathway by counting the number of cells
expressing both BrdU and DCX (Figure 22). This pathway is the well-characterized
rostral migratory stream. We found TBI significantly elevated SVZ-OB migration
(Figure 23). However, alcohol did not have a significant effect on SVZ-OB
migration.
Future Directions
Although we did not examine neurogenesis in the hippocampus, it is
possible that binge alcohol might also affect hippocampal neurogenesis. In future
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studies, we could first use a hippocampal sensitive functional task to assess binge
alcohol impact on the hippocampal dependent task post TBI. However, we know
that in the hippocampus, reduced NSC proliferation or ablation was shown to lead
to inhibition of LTP in the perforant pathway (Kempermann 2011). Other evidence
suggests that reduced NSC responses can lead to worse performance on
hippocampal dependent tasks such as the MWM, contextual fear conditioning,
and trace conditioning. Additionally, we could extend our work by using the BrdU
injection paradigm to study different temporal responses of neurogenesis to TBI
and alcohol in the hippocampus.
BDNF is responsible for the survival of new neurons. A large number of
newly generated cells die due to insufficient trophic support. Alcohol potently
affects BDNF expression and could affect how many newly generated cells in the
SVZ survive. Our future study could explore how alcohol affects BDNF expression
in TBI animals and in turn how that affects the survival of those new neurons. We
would need to utilize markers of neurogenesis (such as BrdU) along with markers
of cell death (such as Caspase3). Furthermore, our lab is in the process of refining
the method to alter the BDNF level in the SVZ. This would allow us to modulate
the endogenous BDNF and to assess its contribution to neurogenesis after TBI.
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While BrdU has been a useful tool in the study of neurogenesis, there are
important limitations to this technique. One new technology that has been shown
to be useful in the study of neurogenesis is conditional lentivirus expressing CreFlex, a bioluminescence marker in addition to green fluorescence protein (GFP).
This technique utilizes lentivirus and can be used to label neural stem cells in the
SVZ as has been demonstrated recently in a stroke model (Vandeputte et al
2014). The lentivirus vector is introduced into the SVZ by stereotactic injection,
and becomes incorporated into the stem cells of the SVZ. The markers carried by
the lentivirus become stably expressed in the stem cells which allow us to track
the migration pattern as well as determine the eventual phenotype of these cells.
Inflammation is a large component of TBI pathology, and alcohol has a
pronounced inflammatory modulating effect. One question is how binge alcohol
affects inflammatory cells such as infiltrating macrophage, and microglia
activation. In this regard, large amounts of adenosine triphosphate (ATP) is
produced in the cells of TBI lesion sites after CNS injury and released to the
extracellular space and serves as an inflammatory signaling molecule. ATP has
been found to be a potent chemo-attractant to microglia, the resident
inflammatory cell of the CNS (Ohsawa & Kohsaka 2011). Additionally, in the
hematopoietic system, ATP has a chemo-attraction role for stem cells (Rossi et al
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2012). It is likely that ATP also is a homing signal for migrating neuroblasts (i.e.
DCX+ cells). Extracellular ATP is recognized by cells via the purinergic cell surface
receptors such as P2X4 and P2X7. Interestingly, P2X7 receptors are also affected
by alcohol. For instance, alcohol is an antagonist for purinergic receptors P2X4
and P2X7 (Ostrovskaya et al 2011).
Finally, we could expand our binge alcohol model to more closely mimic
human alcohol consumption. Typically, TBI patients do not get a TBI during their
first binge episode. It is likely that they would have a more prolonged history of
alcohol consumption. Since laboratory animals such as rats can experience
tolerant effects to alcohol when given repeatedly over time, this may affect the
outcome of repeated binge alcohol studies. Alcohol is an antagonist for NMDA
receptors and repeated alcohol administration can lead to an increase in
expression of NMDA receptors. We know that NMDA receptors are the main
perpetrator for excitotoxicity via high levels of extracellular glutamate after TBI.
Therefore, it is possible that a more prolonged binge alcohol administration
paradigm could lead to different SVZ response outcomes as compared to what we
observed in our current model. As there is evidence in human TBI patients of a
strong likelihood of increase in intake of alcohol post-TBI (Bombardier et al 2003),
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examining how alcohol given after TBI affects neurogenesis is an interesting
avenue of research.
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